86 results on '"Miglioranza MH"'
Search Results
2. Poster session 4: Friday 5 December 2014, 08: 30–12: 30Location: Poster area
- Author
-
Miglioranza, MH, Muraru, D, Cavalli, G, Addetia, K, Cucchini, U, Mihaila, S, Tadic, M, Veronesi, F, Lang, RM, and Badano, L
- Published
- 2014
3. Poster session 2: Thursday 4 December 2014, 08: 30–12: 30Location: Poster area
- Author
-
Muraru, D, Cavalli, G, Addetia, K, Miglioranza, MH, Veronesi, F, Mihaila, S, Tadic, M, Cucchini, U, Badano, L, and Lang, RM
- Published
- 2014
4. Club 35 Poster session 1: Wednesday 3 December 2014, 09: 00–16: 00Location: Poster area
- Author
-
Miglioranza, MH, Mihaila, S, Muraru, D, Cucchini, U, Cecchetto, A, Cavalli, G, Romeo, G, Iliceto, S, and Badano, LP
- Published
- 2014
5. Club 35 Moderated Poster session: Wednesday 3 December 2014, 09: 00–16: 00Location: Moderated Poster area
- Author
-
Miglioranza, MH, Mihaila, S, Muraru, D, Cucchini, U, Cavalli, G, Cecchetto, A, Romeo, G, Iliceto, S, and Badano, LP
- Published
- 2014
6. Club 35 Poster Session Wednesday 11 December: 11/12/2013, 09: 30–16: 00Location: Poster area
- Author
-
Miglioranza, MH, Gargani, L, Sant`Anna, RT, Rover, M, Martins, VM, Mantovanni, A, Kalil, RK, and Leiria, TL
- Published
- 2013
7. Club 35 Moderated Poster Session - Part B: 11/12/2013, 09: 30–16: 00Location: Moderated Poster area
- Author
-
Miglioranza, MH, Muraru, D, Peluso, D, Cucchini, U, Mihaila, S, Naso, P, Puma, L, Kocabay, G, Iliceto, S, and Badano, LP
- Published
- 2013
8. Poster session: Aortic stenosis
- Author
-
Miglioranza, MH, Santʼanna, RT, Rover, M, Mantovani, A, Lessa, JR, Haertel, JC, Salgado Filho, PA, Kalil, R, and Leiria, TL
- Published
- 2012
9. Poster session: Dobutamine stress echo
- Author
-
Miglioranza, MH, Gargani, L, Santʼanna, RT, Rover, M, Mantovani, A, Kalil, RAK, Sicari, R, Picano, E, and Leiria, TL
- Published
- 2012
10. Isolated anterior mitral valve leaflet cleft: 3D transthoracic echocardiography-guided surgical strategy [Fenda isolada no folheto anterior da valva mitral: Estratégia cirúrgica guiada por ecocardiografia transtorácica tridimensional]
- Author
-
MIGLIORANZA MH, MURARU D, MIHAILA S, HAERTEL JC, ILICETO S, BADANO LP, Miglioranza, M, Muraru, D, Mihaila, S, Haertel, J, Iliceto, S, and Badano, L
- Subjects
Heart Valve Prosthesis Implantation ,Male ,Adolescent ,Interventional ,Medicine (all) ,Doppler ,Color ,Mitral Valve Insufficiency ,Reproducibility of Result ,Heart defect ,Congenital ,Treatment Outcome ,Echocardiography ,Three-Dimensional ,Mitral Valve ,Cardiology and Cardiovascular Medicine ,Human ,Ultrasonography - Published
- 2015
11. In patients with organic mitral regurgitation and normal left ventricular systolic function, mitral valve leaflet flail is associated with reduced shortening of the mitral annulus area
- Author
-
Mihaila, S, Aruta, Patrizia, Muraru, Denisa, Miglioranza, Mh, Cavalli, Giacomo, Piasentini, Eleonora, Iliceto, Sabino, Vinereanu, D, and Badano, Luigi
- Published
- 2014
12. Three-dimensional tricuspid annulus surface area is a better predictor of functional tricuspid regurgitation severity than conventional 2D-echocardiography diameters
- Author
-
Miglioranza, Mh, Muraru, Denisa, Cavalli, Giacomo, Addetia, K, Cucchini, Umberto, Mihaila, S, Tadic, M, Veronesi, F, Lang, Rm, and Badano, Luigi
- Published
- 2014
13. Left ventricular myocardial strain by three-dimensional speckle-tracking echocardiography in healthy volunteers: a normative study
- Author
-
Muraru, Denisa, Cucchini, Umberto, PADAYATTIL JOSE, Seena, Mihaila, S, Miglioranza, Mh, Cecchetto, Aantonella, Casablanca, S, Iliceto, Sabino, and Badano, Luigi
- Published
- 2014
14. In patients with functional tricuspid regurgitation, tricuspid annulus size by 3D echocardiography is closely related to right heart chamber volumes
- Author
-
Muraru, Denisa, Cavalli, Giacomo, Addetia, K, Miglioranza, Mh, Veronesi, F, Mihaila, S, Tadic, M, Cucchini, Umberto, Badano, Luigi, and Lang, Rm
- Published
- 2014
15. Relationships between the severity of the regurgitation and the geometry of the tricuspid annulus in patients with functional tricuspid regurgitation
- Author
-
Cavalli, Giacomo, Muraru, Denisa, Miglioranza, Mh, Addetia, K, Veronesi, F, Cucchini, Umberto, Mihaila, M, Tadic, M, Lang, Rm, and Badano, Luigi
- Published
- 2014
16. Normative study of left atrium phasic volumetric changes by two-dimensional echocardiography in 230 healthy volunteers
- Author
-
Miglioranza, Mh, Mihaila, S, Muraru, Denisa, Cucchini, Umberto, Cecchetto, Antonella, Cavalli, Giacomo, Romeo, Gabriella, Iliceto, Sabino, and Badano, Luigi
- Published
- 2014
17. Isolated anterior mitral valve leaflet cleft: 3D transthoracic echocardiography-guided surgical strategy [Fenda isolada no folheto anterior da valva mitral: Estratégia cirúrgica guiada por ecocardiografia transtorácica tridimensional]
- Author
-
Miglioranza, M, Muraru, D, Mihaila, S, Haertel, J, Iliceto, S, Badano, L, MIGLIORANZA MH, MURARU D, MIHAILA S, HAERTEL JC, ILICETO S, BADANO LP, Miglioranza, M, Muraru, D, Mihaila, S, Haertel, J, Iliceto, S, Badano, L, MIGLIORANZA MH, MURARU D, MIHAILA S, HAERTEL JC, ILICETO S, and BADANO LP
- Published
- 2015
18. HIT Moderated Poster session: imaging in everyday practiceP143Relationship of FDG-PET and pressure-strain loops as novel measures of regional myocardial workload in LBBB-like dyssynchronyP144Cardiotoxicity of anti-vascular endothelial growth factor therapies: results of a pilot studyP145A new animal model of rapid pacing-induced dilated cardiomyopathy and LBBBP146Three-dimensional echocardiography assessment of the systolic variation of effective regurgitant orifice area in patients with functional tricuspid regurgitation: implications for quantificationP147Clinical prognostic value of myocardial mechanics using speckle-tracking echocardiography in patients post primary coronary intervention for acute ST- segment elevation myocardial infarctionP148Relationship between left atrial volumes and emptying fractions and parameters of infarct size and left ventricular filling pressures in survivors of st elevation myocardial infarctionP149Left atrial dysfunction assessed by two dimensional speckle tracking echocardiography in patients with impaired left ventricular ejection fraction and sleep-disordered breathingP150Left atrial morphological and functional remodeling early after ST elevation myocardial infarction insights from threedimensional echocardiographyP151Circumferential strain and strain rate at early stages of dobutamine speckle tracking imaging: are they enough to detect ischemia in patients with coronary artery disease?P152Pulmonary hypertension in hypertrophic cardiomyopathy: a rest and exercise echocardiography study
- Author
-
Duchenne, J, primary, Popara-Voica, AM, primary, Aruta, P, primary, Teo, HK, primary, Onciul, S, primary, Miskowiec, D, primary, Rumbinaite, E, primary, Abellard, JA, primary, Turco, A, additional, Claus, P, additional, Vunckx, K, additional, Pagourelias, E, additional, Rega, F, additional, Gheysens, O, additional, Voigt, JU, additional, Croitoru, A, additional, Alexandru, D, additional, Geavlete, D O, additional, Popescu, B A, additional, Ginghina, C, additional, Jurcut, R, additional, Haemers, P, additional, Van Puyvelde, J, additional, Muraru, D, additional, Janei, C, additional, Haertel Miglioranza, M, additional, Cavalli, G, additional, Romeo, G, additional, Peluso, D, additional, Cucchini, U, additional, Iliceto, S, additional, Badano, L, additional, Kui, SL, additional, Chai, SC, additional, Leong, KT, additional, Tong, KL, additional, Miglioranza, MH, additional, Dorobantu, M, additional, Badano, LP, additional, Kupczynska, K, additional, Uznanska-Loch, B, additional, Kasprzak, JD, additional, Kurpesa, M, additional, Lipiec, P, additional, Vaskelyte, JJ, additional, Lapinskas, T, additional, Karuzas, A, additional, Zvirblyte, R, additional, Viezelis, M, additional, Jonauskiene, I, additional, Gustiene, O, additional, Slapikas, R, additional, Trochu, JN, additional, Gueffet, JP, additional, Cueff, C, additional, De Groote, P, additional, Bauters, C, additional, Millaire, A, additional, Polge, AS, additional, and Le Tourneau, T, additional
- Published
- 2015
- Full Text
- View/download PDF
19. HIT Poster session 1P154Preclinical diastolic dysfunction is related to impaired endothelial function in patients with chronic kidney diseaseP155Early detection of left atrial and left ventricular abnormalities in hypertensive and obese womenP156Right ventricle preserved systolic function irrespective of right ventricular hypertrophy and disease severity in anderson fabry diseaseP157Left atrial volume and function in patients undergoing percutaneous mitral valve repairP158Impact of left ventricular dysfunction on outcomes of patients undergoing direct TAVI with a self-expanding bioprosthesisP159Anatomic Doppler spectrum – retrospective spectral tissue Doppler from ultra high frame rate tissue Doppler imaging for evaluation of tissue deformationP160Phasic dynamics of ischaemic mitral regurgitation after primary coronary intervention in acute myocardial infarction: serial echocardiographic assessment from emergency room to long-term follow-upP161Reproducibility of 3DE RV volumes - novel insights at a regional levelP162Pulmonary vascular capacitance as assessed by echocardiography in pulmonary arterial hypertensionP163Three-dimensional endocardial area strain: a novel parameter for quantitative assessment of global left ventricular systolic functionP164Role of exercise hemodynamics assessed by echocardiography on symptom reduction after MitraClipP165Early identification of ventricular dysfunction in patients with juvenile systemic sclerosisP166Heart failure with and without preserved ejection fraction - the role of biomarkers in the aspect of global longitudinal strainP167Complex systolic deformation of aortic root: insights from two dimensional speckle tracking imageP168Volumetric and deformational imaging usind 2d strain and 3d echocardiography in patients with pulmonary hypertensionP169Influence of pressure load and right ventricular morphology and function on tricuspid regurgitation in pulmonary arterial hypertensionP170Left ventricular myocardial diastolic deformation analysis by 2D speckle tracking echocardiography and relationship with conventional diastolic parameters in chronic aortic regurgitationP171Extracellular volume, and not native T1 time, distinguishes diffuse fibrosis in dilated or hypertrophic cardiomyopathy at 3TP172Left atrial strain is significantly reduced in arterial hypertensionP173Symptomatic severe secondary mitral regurgitation: LV enddiastolic diameter (LVEDD) as preferable parameter for risk stratificationP174Left ventricular mechanics in isolated left bundle branch block at rest and when exercising: exploration of the concept of conductive cardiomyopathyP175Assessment of myocardial scar by 2D contrast echocardiographyP176Chronic pericarditis - expression of a rare disease: Erdheim Chester diseaseP177Aortic arch mechanics with two-dimensional speckle tracking echocardiography to estimate the left ventricular remodelling in hypertensive patientsP178Strain analysis by tissue doppler imaging: comparison of conventional manual measurement with a semi-automated approachP179Distribution of extravascular lung water in heart failure patients assessed by lung ultrasoudP180Surrogate markers for obstructive coronary artery diseaseP181LA deformation and LV longitudinal strain by two-dimensional speckle tracking echocardiography as predictors of postoperative AF development after aortic valve replacement in ASP182Left ventricular diastolic dysfunction in type 2 diabetic patients with non alcoholic fatty liver diseaseP183Myocardial strain by speckle-tracking and evaluation of 3D ejection fraction in drug-induced cardiotoxicity's approach in breast cancer
- Author
-
Gevaert, AB, primary, Borizanova, A, primary, Graziani, F, primary, Galuszka, O M, primary, Stathogiannis, K, primary, Lervik Nilsen, L C, primary, Nishino, S, primary, Willis, J, primary, Venner, C, primary, Luo, XX, primary, Van De Heyning, C M, primary, Castaldi, B, primary, Michalski, BW, primary, Wang, TL, primary, Aktemur, T, primary, Dorlet, S, primary, Verseckaite, R, primary, Amzulescu, MS, primary, Brecht, A, primary, Brand, M, primary, Galli, E, primary, Murzilli, R, primary, Bica, R, primary, Teixeira, R, primary, Schmid, J, primary, Miglioranza, MH, primary, Cherneva, ZH, primary, Gheghici, S, primary, Pernigo, M, primary, Rafael, D, primary, Van Craenenbroeck, AH, additional, Shivalkar, B, additional, Lemmens, K, additional, Vrints, CJ, additional, Van Craenenbroeck, EM, additional, Somleva, D, additional, Zlatareva- Gronkova, N, additional, Kinova, E, additional, Goudev, A, additional, Camporeale, A, additional, Pieroni, M, additional, Pedicino, D, additional, Laurito, MP, additional, Verrecchia, E, additional, Lanza, GA, additional, Manna, R, additional, Crea, F, additional, Reinthaler, M, additional, Rutschow, S, additional, Gross, M, additional, Landmesser, U, additional, Kasner, M, additional, Toutouzas, K, additional, Drakopoulou, M, additional, Latsios, G, additional, Synetos, A, additional, Kaitozis, O, additional, Trantalis, G, additional, Mastrokostopoulos, A, additional, Kotronias, R, additional, Tousoulis, D, additional, Brekke, BB, additional, Aase, SA, additional, Lonnebakken, MT, additional, Stensvag, D, additional, Amundsen, B, additional, Torp, H, additional, Stoylen, A, additional, Watanabe, N, additional, Kimura, T, additional, Nakama, T, additional, Furugen, M, additional, Koiwaya, H, additional, Ashikaga, K, additional, Kuriyama, N, additional, Shibata, Y, additional, Augustine, DX, additional, Knight, D, additional, Sparey, J, additional, Coghlan, G, additional, Easaw, J, additional, Huttin, O, additional, Voilliot, D, additional, Mercy, M, additional, Villemin, T, additional, Olivier, A, additional, Mandry, D, additional, Chaouat, A, additional, Juilliere, Y, additional, Selton-Suty, C, additional, Fang, F, additional, Li, S, additional, Zhang, ZH, additional, Yu, CM, additional, Bertrand, PB, additional, De Maeyer, C, additional, De Bock, D, additional, Paelinck, BP, additional, Claeys, MJ, additional, Reffo, E, additional, Balzarin, M, additional, Zulian, F, additional, Milanesi, O, additional, Miskowiec, D, additional, Kupczynska, K, additional, Peczek, L, additional, Nawrot, B, additional, Lipiec, P, additional, Kasprzak, JD, additional, Li, H, additional, Jin, XY, additional, Poci, N, additional, Kaymaz, C, additional, Venner, C, additional, Manenti, V, additional, Carillo, S, additional, Chabot, F, additional, Mizariene, V, additional, Rimkeviciute, D, additional, Bieseviciene, M, additional, Jonkaitiene, R, additional, Jurkevicius, R, additional, Roy, C, additional, Slimani, A, additional, Boileau, L, additional, De Meester, C, additional, Vancraeynest, D, additional, Pasquet, A, additional, Vanoverschelde, JL, additional, Pouleur, AC, additional, Gerber, BL, additional, Oertelt-Prigione, S, additional, Seeland, U, additional, Ruecke, M, additional, Regitz-Zagrosek, V, additional, Stangl, V, additional, Knebel, F, additional, Laux, D, additional, Roeing, J, additional, Butz, T, additional, Christ, M, additional, Grett, M, additional, Wennemann, R, additional, Trappe, H- J, additional, Fournet, M, additional, Leclercq, C, additional, Samset, E, additional, Daubert, J-C, additional, Donal, E, additional, Leo, LA, additional, Pasotti, E, additional, Klersy, C, additional, Moccetti, T, additional, Faletra, FF, additional, Dobre, D, additional, Darmon, S, additional, Dumitrescu, S, additional, Calistru, P, additional, Monteiro, R, additional, Ribeiro, M, additional, Garcia, J, additional, Cardim, N, additional, Goncalves, L, additional, Kaufmann, R, additional, Grubler, MR, additional, Verheyen, N, additional, Weidemann, F, additional, Binder, JS, additional, Santanna, RT, additional, Rover, MM, additional, Leiria, T, additional, Kalil, R, additional, Picano, E, additional, Gargani, L, additional, Kuneva, ZK, additional, Vasilev, DV, additional, Ianula, R, additional, Dasoveanu, M, additional, Calin, C, additional, Homentcovsci, C, additional, Siliste, R, additional, Bergamini, C, additional, Mantovani, A, additional, Bonapace, S, additional, Lipari, P, additional, Barbieri, E, additional, Bonora, E, additional, Targher, G, additional, Camarozano, AC, additional, Pereira Da Cunha, CL, additional, Padilha, SL, additional, Souza, AM, additional, and Freitas, AKE, additional
- Published
- 2015
- Full Text
- View/download PDF
20. HIT Poster session 2P486The effect of short term aerobic exercise and ACE polymorphism on cardiovascular remodeling in healthy sedentary postmenopausal womenP487Are there predictors of malignant progression of aortic stenosis severity?P488Quantitative und semiquantitative parameters in the classification of aortic insufficiency: a 3D-echocardiography and magnet resonance imaging studyP489Vascular indicies surrogate markers for left ventricular dysfunctionP490Left ventricular systolic strain data does not require indexation to cavity size in mitral valve diseasesP491Impact of EACVI grant programme on career progression of grant winnersP492Early predictor of atrial fibrillation recurrence after electrical cardioversion: diastolic parameters come firstP493Echocardiographic diagnosis of arrhythmias in the fetusP4943D echocardiography is a fast-learning and a more reliable method compared with 2D echocardiography for the assessment of left ventricular volumes and ejection fraction in patients with heart failureP495Right ventricular mechanics in functional ischemic mitral regurgitation in acute inferior myocardial infarctionP496Added value of two dimentional strain in assessement of left ventricular systolic function in rheumatic mitral stenosis patients with normal ejection fractionP497Left ventricular myocardial deformation in arterial hypertension with different types of glucose metabolism disordersP498Epicardial to pericardial adipose tissue ratio: predicting myocardial ischemia in patients referred for exercise stress echocardiographyP499Echocardiographic evaluation of the patients with asd after percutaneous closureP500Screening for carotid artery stenosis with the use of pocket-size imaging device equipped with linear probeP501LAD correlates poorly with LAVIP502Predictors associated with the diastolic dysfunction formation in patients with moderate hypertensionP503Assessment of left atrial function by speckle tracking analysis in transthoracic echocardiography for predicting the presence of left atrial appendage thrombus in patients with atrial fibrillationP504can echocardiography detect subclinical myocardial damage in the layers of myocardial wall? (The first study in a large population with known inflammatory disease)P505Epicardial fat thickness and galectin 3 in patients with atrial fibrillation and metabolic syndromeP506Left ventricular reverse remodeling in heart failure: a new obesity paradox?P507Epicardial adipose tissue and carotid intima media thickness in hemodialysis patients; single center experienceP508Echocardiographic parameters of mitral valve remodeling associated with poor clinical outcome in high risk patients with functional mitral regurgitation after Mitraclip implantationP509Prevalence of valve disease in a community population over the age of 60P510Discordance between mitral valve area and mean transmitral pressure gradient in mitral stenosis: Is mean gradient marker of the severity or parameter of tolerance in severe mitral stenosis?P511Ischemic mitral regurgitation is associated with impaired radial and circumferential myocardial deformation in acute inferoposterior myocardial infarctionP512The importance of early left atrial functional changes in predicting long term left ventricular remodeling in patients surviving a ST elevation myocardial infarctionP513Remodeling of myocardial deformation after mitral valve surgeryP514Global longitudinal peak systolic strain is reduced shortly after heart transplantationP515Detailed transthoracic and transesophageal echocardiographic analysis of mitral leaflets in patient undergoing mitral valve repair
- Author
-
Bucciarelli, V, primary, Avenatti, E, primary, Rosner, SJ, primary, Cherneva, ZHCH, primary, Li, H, primary, Surkova, E A, primary, Degiovanni, A, primary, Ortiz Garrido, A, primary, Mihaila, S, primary, Tamulenaite, E, primary, Amorouayeche, F Z, primary, Kolesnyk, M Y, primary, Garcia Campos, A, primary, Savcioglu, AS, primary, Filipiak, D, primary, Kuusisto, J K, primary, Torbas, O, primary, Kupczynska, K, primary, Tountas, X, primary, Ionin, VA, primary, Cescau, A, primary, Altin, C, primary, Ferreiro Quero, C, primary, Lowery, C, primary, Najih, H, primary, Valuckiene, Z, primary, Onciul, S, primary, Yang, L-T, primary, Baricevic, Z, primary, Ghulam Ali, S, primary, Bianco, F, additional, Izzicupo, P, additional, Ghinassi, B, additional, Di Baldassarre, A, additional, Gallina, S, additional, Milazzo, V, additional, Milan, A, additional, Patel, A, additional, Kuvin, J, additional, Pandian, N, additional, Orban, M, additional, Nadjiri, J, additional, Lesevic, H, additional, Hadamitzky, M, additional, Sonne, C, additional, Kuneva, ZK, additional, Vasilev, DV, additional, Yuan, L, additional, Xie, MX, additional, Jin, XY, additional, Muraru, D, additional, Grapsa, J, additional, Donal, E, additional, Lancellotti, P, additional, Habib, G, additional, Badano, L P, additional, Buffa, MC, additional, De Vecchi, F, additional, Prenna, E, additional, Boggio, E, additional, Marino, P, additional, De La Chica, J, additional, Cuenca Peiro, V, additional, Picazo Angelin, B, additional, Conejo Munoz, L, additional, Narbona, I, additional, Anderica, JR, additional, De Mora, M, additional, Zabala Arguelles, JI, additional, Velcea, A, additional, Matei, L, additional, Andronic, A, additional, Calin, S, additional, Rimbas, R, additional, Badano, LP, additional, Vinereanu, D, additional, Ovsianas, J, additional, Valuckiene, Z, additional, Jurkevicius, R, additional, Latreche, S, additional, Benkhedda, S, additional, Dzyak, G V, additional, Riznyk, Y Y, additional, Kovalyova, O V, additional, Velasco-Alonso, E, additional, Colunga-Blanco, S, additional, Martin-Fernandez, M, additional, Corros-Vicente, C, additional, Rodriguez-Suarez, ML, additional, Leon-Aguero, V, additional, De La Hera Galarza, JM, additional, Safak, O, additional, Nazli, C, additional, Akyildiz Akcay, F, additional, Yakar Tuluce, S, additional, Kahya Eren, N, additional, Ozdemir, E, additional, Kocabas, U, additional, Kasprzak, JD, additional, Lipiec, P, additional, Jarvinen, VM, additional, Sinisalo, JP, additional, Sirenko, YU, additional, Radchenko, G, additional, Rekovets, O, additional, Kushnir, S, additional, Michalski, BW, additional, Miskowiec, D, additional, Wdowiak-Okrojek, K, additional, Wejner-Mik, P, additional, Beldekos, D, additional, Protogerou, A, additional, Gournizakis, A, additional, Panopoulos, S, additional, Theodosis-Georgilas, A, additional, Fousas, S, additional, Sfikakis, P, additional, Soboleva, AV, additional, Listopad, OV, additional, Nifontov, SE, additional, Polyakova, EA, additional, Belyaeva, OD, additional, Baranova, EI, additional, Shlyachto, EV, additional, Baudet, M, additional, Cohen-Solal, A, additional, Logeart, D, additional, Sakallioglu, O, additional, Aydin, E, additional, Yilmaz, M, additional, Sade, LE, additional, Muderrisoglu, H, additional, Mesa Rubio, M D, additional, Ruiz Ortiz, M, additional, Delgado Ortega, M, additional, Sanchez Fernandez, J, additional, Duran Jimenez, E, additional, Morenate Navio, C, additional, Romero, M, additional, Pan, M, additional, Suarez De Lezo, J, additional, Frenneaux, M P, additional, Parasuraman, S K, additional, Rudd, A E, additional, Srinivasan, J, additional, Elbaghdadi, D, additional, Laarej, A, additional, Allouch, M, additional, Azzouzi, L, additional, Habbal, R, additional, Mizariene, V, additional, Ablonskyte-Dudoniene, R, additional, Cucchini, U, additional, Miglioranza, MH, additional, Dorobantu, M, additional, Iliceto, S, additional, Tsai, WC, additional, Cikes, M, additional, Ljubas Macek, J, additional, Skoric, B, additional, Skorak, I, additional, Jurin, H, additional, Samardzic, J, additional, Gasparovic, H, additional, Milicic, D, additional, Separovic Hanzevacki, J, additional, Fusini, L, additional, Tamborini, G, additional, Gripari, P, additional, Muratori, M, additional, Celeste, F, additional, Carminati, MC, additional, Alamanni, F, additional, and Pepi, M, additional
- Published
- 2015
- Full Text
- View/download PDF
21. Two-dimensional assessment of tricuspid annulus dynamics and diameters: study for new reference values
- Author
-
Miglioranza, MH, Muraru, D, Peluso, D, Cucchini, U, Mihaila, S, Naso, P, Puma, L, Kocabay, G, Iliceto, S, Badano, L, Miglioranza, M, Muraru, D, Peluso, D, Cucchini, U, Mihaila, S, Naso, P, Puma, L, Kocabay, G, Iliceto, S, and Badano, L
- Abstract
Background: Tricuspid annulus (TA) size and function plays an important role in decision-making process about the need of associated TA annuloplasty during left sided cardiac surgery. Recommendations about echo assessment of TA don't indicate the view and the timing where TA should be measured. Our aim was to study TA diameters and shortening in different 2D TTE views to assess the extent of their variability. Methods: Cross-sectional study of normal volunteers. TA was measured from 3 2DTTE views (apical 4-CH, LAX-RV inflow, SAX basal) at 5 time points during cardiac cycle. TA fractional shortening diameter was obtained as (TV opening early-filling – Mid-systole) / TV opening early-filling. Result: 100pts; 42%male; 44±13yrs. TA diameters are in the Table. Fractional shortening of TA was 22±7%, 18±8%, 31±16% in 4-CH, LAX-RV inflow and SAX basal views respectively. Conclusion: This study support new references values for TA evaluation using 2D TTE. Values vary according to 2D TTE view and cardiac cycle time, showing the dynamism and complex geometry of TA
- Published
- 2013
22. Two-dimensional assessment of tricuspid annulus dynamics and diameters: study for new reference values
- Author
-
Miglioranza, M, Muraru, D, Peluso, D, Cucchini, U, Mihaila, S, Naso, P, Puma, L, Kocabay, G, Iliceto, S, Badano, L, Miglioranza, MH, Miglioranza, M, Muraru, D, Peluso, D, Cucchini, U, Mihaila, S, Naso, P, Puma, L, Kocabay, G, Iliceto, S, Badano, L, and Miglioranza, MH
- Abstract
Background: Tricuspid annulus (TA) size and function plays an important role in decision-making process about the need of associated TA annuloplasty during left sided cardiac surgery. Recommendations about echo assessment of TA don't indicate the view and the timing where TA should be measured. Our aim was to study TA diameters and shortening in different 2D TTE views to assess the extent of their variability. Methods: Cross-sectional study of normal volunteers. TA was measured from 3 2DTTE views (apical 4-CH, LAX-RV inflow, SAX basal) at 5 time points during cardiac cycle. TA fractional shortening diameter was obtained as (TV opening early-filling – Mid-systole) / TV opening early-filling. Result: 100pts; 42%male; 44±13yrs. TA diameters are in the Table. Fractional shortening of TA was 22±7%, 18±8%, 31±16% in 4-CH, LAX-RV inflow and SAX basal views respectively. Conclusion: This study support new references values for TA evaluation using 2D TTE. Values vary according to 2D TTE view and cardiac cycle time, showing the dynamism and complex geometry of TA
- Published
- 2013
23. HIT Moderated Poster session: imaging in everyday practice
- Author
-
Duchenne, J, Turco, A, Claus, P, Vunckx, K, Pagourelias, E, Rega, F, Gheysens, O, Voigt, JU, Popara-Voica, AM, Croitoru, A, Alexandru, D, Geavlete, D O, Popescu, B A, Ginghina, C, Jurcut, R, Duchenne, J, Claus, P, Turco, A, Vunckx, K, Pagourelias, E, Haemers, P, Van Puyvelde, J, Gheysens, O, Rega, F, Voigt, JU, Aruta, P, Muraru, D, Janei, C, Haertel Miglioranza, M, Cavalli, G, Romeo, G, Peluso, D, Cucchini, U, Iliceto, S, Badano, L, Teo, HK, Kui, SL, Chai, SC, Leong, KT, Tong, KL, Onciul, S, Muraru, D, Miglioranza, MH, Cucchini, U, Dorobantu, M, Iliceto, S, Badano, LP, Miskowiec, D, Kupczynska, K, Uznanska-Loch, B, Kasprzak, JD, Kurpesa, M, Lipiec, P, Onciul, S, Muraru, D, Miglioranza, MH, Cucchini, U, Dorobantu, M, Iliceto, S, Badano, LP, Rumbinaite, E, Vaskelyte, JJ, Lapinskas, T, Karuzas, A, Zvirblyte, R, Viezelis, M, Jonauskiene, I, Gustiene, O, Slapikas, R, Abellard, JA, Trochu, JN, Gueffet, JP, Cueff, C, De Groote, P, Bauters, C, Millaire, A, Polge, AS, and Le Tourneau, T
- Abstract
Purpose: To investigate the relationship between two measures of regional myocardial workload (RMW): regional myocardial glucose metabolism, assessed by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and regional LV pressure-strain loop area. Both were evaluated in a chronic rapid pacing animal model of dilated cardiomyopathy (DCM) and LBBB-like mechanical dyssynchrony. Methods: Nine sheep were subjected to rapid RV pacing (180 bpm), developing LV dilatation and asymetric remodelling, with LBBB-like ventricular activation. After 8 weeks all animals underwent two FDG-PET scans: one under normal LV conduction (AAI pacing), another under LBBB-like activation (DDD pacing). Potential inhomogeneities in RMW represented by FDG-uptake, were then evaluated. Before the last PET scan, all animals were subjected to invasive pressure-volume and simultaneous echocardiographic circumferential strain (CS) analysis of the mid-ventricular segments. Segmental pressure-CS-loop area was then recorded as alternative measure of RMW and compared to PET results. Results: DDD and AAI pacing led to different, but reproducible patterns of inhomogeneous RMW distribution (Figure) with a significant decreased septal-to-lateral wall ratio of RMW in DDD mode compared to AAI, both in the FDG-uptake (0.87 ± 0.09 vs 1.05 ± 0.15, resp., p=0.005) and pressure-strain loops area (0.22 ± 0.18 vs 0.94 ± 0.23, resp., p=0.0001). A significant correlation was found between both measures (r=0.584, p=0.018). Conclusions: Our study indicates that RMW can be measured with both regional FDG-uptake and the area of regional pressure-strain loops. The influence of motion and partial volume on the reconstructed FDG-uptake in the asymmetrically remodelled hearts is currently being investigated.
- Published
- 2015
- Full Text
- View/download PDF
24. Is it Time for Ultrasound in Cardiac Arrest?
- Author
-
Miglioranza MH and Barbisan JN
- Published
- 2010
- Full Text
- View/download PDF
25. HIT Poster session 2
- Author
-
Bucciarelli, V, Bianco, F, Izzicupo, P, Ghinassi, B, Di Baldassarre, A, Gallina, S, Avenatti, E, Milazzo, V, Milan, A, Patel, A, Kuvin, J, Pandian, N, Rosner, SJ, Orban, M, Nadjiri, J, Lesevic, H, Hadamitzky, M, Sonne, C, Cherneva, ZHCH, Kuneva, ZK, Vasilev, DV, Li, H, Yuan, L, Xie, MX, Jin, XY, Surkova, E A, Muraru, D, Grapsa, J, Donal, E, Lancellotti, P, Habib, G, Badano, L P, Degiovanni, A, Buffa, MC, De Vecchi, F, Prenna, E, Boggio, E, Marino, P, Ortiz Garrido, A, De La Chica, J, Cuenca Peiro, V, Picazo Angelin, B, Conejo Munoz, L, Narbona, I, Anderica, JR, De Mora, M, Zabala Arguelles, JI, Mihaila, S, Velcea, A, Matei, L, Andronic, A, Calin, S, Rimbas, R, Muraru, D, Badano, LP, Vinereanu, D, Tamulenaite, E, Ovsianas, J, Valuckiene, Z, Jurkevicius, R, Amorouayeche, F Z, Latreche, S, Benkhedda, S, Kolesnyk, M Y, Dzyak, G V, Riznyk, Y Y, Kovalyova, O V, Garcia Campos, A, Velasco-Alonso, E, Colunga-Blanco, S, Martin-Fernandez, M, Corros-Vicente, C, Rodriguez-Suarez, ML, Leon-Aguero, V, De La Hera Galarza, JM, Savcioglu, AS, Safak, O, Nazli, C, Akyildiz Akcay, F, Yakar Tuluce, S, Kahya Eren, N, Ozdemir, E, Kocabas, U, Filipiak, D, Kasprzak, JD, Lipiec, P, Kuusisto, J K, Jarvinen, VM, Sinisalo, JP, Torbas, O, Sirenko, YU, Radchenko, G, Rekovets, O, Kushnir, S, Kupczynska, K, Michalski, BW, Miskowiec, D, Kasprzak, JD, Wdowiak-Okrojek, K, Wejner-Mik, P, Lipiec, P, Tountas, X, Beldekos, D, Protogerou, A, Gournizakis, A, Panopoulos, S, Theodosis-Georgilas, A, Fousas, S, Sfikakis, P, Ionin, VA, Soboleva, AV, Listopad, OV, Nifontov, SE, Polyakova, EA, Belyaeva, OD, Baranova, EI, Shlyachto, EV, Cescau, A, Baudet, M, Cohen-Solal, A, Logeart, D, Altin, C, Sakallioglu, O, Aydin, E, Yilmaz, M, Sade, LE, Muderrisoglu, H, Ferreiro Quero, C, Mesa Rubio, M D, Ruiz Ortiz, M, Delgado Ortega, M, Sanchez Fernandez, J, Duran Jimenez, E, Morenate Navio, C, Romero, M, Pan, M, Suarez De Lezo, J, Lowery, C, Frenneaux, M P, Parasuraman, S K, Rudd, A E, Srinivasan, J, Najih, H, Elbaghdadi, D, Laarej, A, Allouch, M, Azzouzi, L, Habbal, R, Valuckiene, Z, Ovsianas, J, Mizariene, V, Ablonskyte-Dudoniene, R, Jurkevicius, R, Onciul, S, Cucchini, U, Miglioranza, MH, Dorobantu, M, Iliceto, S, Badano, LP, Muraru, D, Yang, L-T, Tsai, WC, Baricevic, Z, Cikes, M, Ljubas Macek, J, Skoric, B, Skorak, I, Jurin, H, Samardzic, J, Gasparovic, H, Milicic, D, Separovic Hanzevacki, J, Ghulam Ali, S, Fusini, L, Tamborini, G, Gripari, P, Muratori, M, Celeste, F, Carminati, MC, Alamanni, F, and Pepi, M
- Abstract
Background: Menopause is associated with worsening of cardiovascular (CV) risk factors that can be counteract by physical exercise. Between angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism, the deletion variant (DD) is related to higher levels of circulating angiotensin II. We evaluated the effect of a short term endurance exercise program on CV remodeling, by means of 2-D echocardiography, among healthy, sedentary, postmenopausal women with ACE I/D genotypes. Methods: Fifty-three women (mean age 56 ± 4 years) underwent a 4 months moderate intensity walking training, eliciting an effort equal to 11-12 according the rating of perceived exertion scale (RPE). Partecipants' attendance at physical exercise program was 85.90 ± 10.75%. The ACE genotype was ascertained by polimerase chain reaction (DD in 20; ID in 27) before (T0) and after training (T1), along with laboratory, anthropometric and echocardiographic measurements. Results: We observed in both groups a significant reduction in systolic and diastolic blood pressure, weight and body mass index, along with a significant increase in left ventricular ejection fraction and diastolic function. Only ID group showed a significant decrease in heart rate and relative wall thickness [RWT ± SD] (T0 0.42 ± 0.06 – T1 0.40 ± 0.05, P 0.04), with a significant increase in left ventricular mass index [LVMI, g/m(2.7) ± SD] (T0 44.58 ± 11.28 – T1 47.34 ± 9.94, P 0.004) and in right ventricular systolic function, assessed by tricuspid annular plane systolic excursion [TAPSE, mm ± SD] (T0 22.52 ± 0.3 – T1 22.96 ± 0.3, P 0.03). Conclusions: Short term aerobic exercise program ameliorates CV profile in healthy, sedentary, postmenopausal women and is associated with positive left ventricular remodeling in ID patients. Enhanced ACE activity, as in DD genotype, could reduce this phenomenon. Thus, ACE polymorphism could account for the individual cardiac remodeling response to physical exercise and should be considered in order to optimize CV prevention measures.
- Published
- 2015
- Full Text
- View/download PDF
26. HIT Poster session 1
- Author
-
Gevaert, AB, Van Craenenbroeck, AH, Shivalkar, B, Lemmens, K, Vrints, CJ, Van Craenenbroeck, EM, Borizanova, A, Somleva, D, Zlatareva- Gronkova, N, Kinova, E, Goudev, A, Graziani, F, Camporeale, A, Pieroni, M, Pedicino, D, Laurito, MP, Verrecchia, E, Lanza, GA, Manna, R, Crea, F, Galuszka, O M, Reinthaler, M, Rutschow, S, Gross, M, Landmesser, U, Kasner, M, Stathogiannis, K, Toutouzas, K, Drakopoulou, M, Latsios, G, Synetos, A, Kaitozis, O, Trantalis, G, Mastrokostopoulos, A, Kotronias, R, Tousoulis, D, Lervik Nilsen, L C, Brekke, BB, Aase, SA, Lonnebakken, MT, Stensvag, D, Amundsen, B, Torp, H, Stoylen, A, Nishino, S, Watanabe, N, Kimura, T, Nakama, T, Furugen, M, Koiwaya, H, Ashikaga, K, Kuriyama, N, Shibata, Y, Willis, J, Augustine, DX, Knight, D, Sparey, J, Coghlan, G, Easaw, J, Venner, C, Huttin, O, Voilliot, D, Mercy, M, Villemin, T, Olivier, A, Mandry, D, Chaouat, A, Juilliere, Y, Selton-Suty, C, Luo, XX, Fang, F, Li, S, Zhang, ZH, Yu, CM, Van De Heyning, C M, Bertrand, PB, De Maeyer, C, De Bock, D, Paelinck, BP, Vrints, CJ, Claeys, MJ, Castaldi, B, Reffo, E, Balzarin, M, Zulian, F, Milanesi, O, Michalski, BW, Miskowiec, D, Kupczynska, K, Peczek, L, Nawrot, B, Lipiec, P, Kasprzak, JD, Wang, TL, Li, H, Jin, XY, Aktemur, T, Poci, N, Kaymaz, C, Dorlet, S, Huttin, O, Voilliot, D, Venner, C, Villemin, T, Manenti, V, Carillo, S, Chabot, F, Juilliere, Y, Selton-Suty, C, Verseckaite, R, Mizariene, V, Rimkeviciute, D, Bieseviciene, M, Jonkaitiene, R, Jurkevicius, R, Amzulescu, MS, Roy, C, Slimani, A, Boileau, L, De Meester, C, Vancraeynest, D, Pasquet, A, Vanoverschelde, JL, Pouleur, AC, Gerber, BL, Brecht, A, Oertelt-Prigione, S, Seeland, U, Ruecke, M, Regitz-Zagrosek, V, Stangl, V, Knebel, F, Brand, M, Laux, D, Roeing, J, Butz, T, Christ, M, Grett, M, Wennemann, R, Trappe, H- J, Galli, E, Fournet, M, Leclercq, C, Samset, E, Daubert, J-C, Donal, E, Murzilli, R, Leo, LA, Pasotti, E, Klersy, C, Moccetti, T, Faletra, FF, Bica, R, Dobre, D, Darmon, S, Dumitrescu, S, Calistru, P, Teixeira, R, Monteiro, R, Ribeiro, M, Garcia, J, Cardim, N, Goncalves, L, Schmid, J, Kaufmann, R, Grubler, MR, Verheyen, N, Weidemann, F, Binder, JS, Miglioranza, MH, Santanna, RT, Rover, MM, Leiria, T, Kalil, R, Picano, E, Gargani, L, Cherneva, ZH, Kuneva, ZK, Vasilev, DV, Gheghici, S, Ianula, R, Dasoveanu, M, Calin, C, Homentcovsci, C, Siliste, R, Pernigo, M, Bergamini, C, Mantovani, A, Bonapace, S, Lipari, P, Barbieri, E, Bonora, E, Targher, G, Rafael, D, Camarozano, AC, Pereira Da Cunha, CL, Padilha, SL, Souza, AM, and Freitas, AKE
- Abstract
Background: Preclinical diastolic dysfunction is highly prevalent in the aging population, but mechanisms for progression into heart failure with preserved ejection fraction (HFpEF) are still obscure. Recently, microvascular endothelial inflammation and endothelial dysfunction (ED) were advocated as primum movens in the development of HFpEF. Purpose: We aimed to evaluate whether ED and arterial stiffness relate to diastolic and other structural and functional cardiac parameters. This was studied in patients with chronic kidney disease (CKD), known to be prone to diastolic dysfunction and left ventricular hypertrophy. Methods: Consecutive CKD patients, without concomitant cardiovascular disease, were included. Diastolic parameters were assessed by cardiac ultrasound using E/
e ´ ratio and left atrial volume index (LAVi). Also, left ventricular mass index (LVMi) and interventricular septum thickness (IVSd) were included. Endothelial function was evaluated by flow-mediated dilation (FMD) of the brachial artery induced by hyperaemia. Arterial stiffness was assessed by measuring carotid-femoral pulsed wave velocity (PWV). Results: After exclusion of patients with normal diastolic function (n=11), 52 patients (age 53.9 ± 12.8 years, 53.2% male) were assessed, of whom 36 underwent a second analysis after 3 months (total measurements 88). Mean creatinin clearance (eGFR) was 42.9 ± 23.2 ml/min/1.73m2. Comorbidities included arterial hypertension (90.4%) and diabetes mellitus (9.6%). Mean Framingham Heart score was 18.9% ± 18.7. Endothelial function was impaired (FMD 4.64% ± 2.61), and patients showed increased arterial stiffness (PWV 8.96 m/s ± 2.18). Ratio of E/e ´ was elevated (>12) in 36.4% of measurements. LVMi was raised in 28.4%, and LAVi was elevated in 45.1%. Patients with E/e ´ >12 had impaired FMD (p=0.005) and elevated PWV (p=0.047). In bivariate correlation analysis, FMD correlated with E/e ´ (r=-0.289, p=0.010) and with IVSd (r=-0.315, p=0.005). PWV did not show a relation with any of the diastolic indices (all p>0.05). In a multiple linear regression model, accounting for age, sex, smoking, eGFR, and PWV, FMD remained independently associated to E/e ´ (ß=-0.279, p=0.011) and IVSd (ß=-0.232, p=0.026). Conclusions: In CKD patients with preclinical diastolic dysfunction, impaired endothelial function correlates with higher filling pressures and structural cardiac changes. This observation supports the paradigm that ED plays a role in the pathophysiology of diastolic dysfunction, even in an asymptomatic stage.- Published
- 2015
- Full Text
- View/download PDF
27. Poster session 6: Saturday 6 December 2014, 08:30-12:30 * Location: Poster area
- Author
-
Goirigolzarri Artaza, J, Gallego Delgado, M, Jaimes Castellanos, CP, Cavero Gibanel, MA, Pastrana Ledesma, MA, Alonso Pulpon, LA, Gonzalez Mirelis, J, Al Ansi, R Z, Sokolovic, S, Cerin, G, Szychta, W, Popa, B A, Botezatu, D, Benea, D, Manganiello, S, Corlan, A, Jabour, A, Igual Munoz, B, Osaca Asensi, JOA, Andres La Huerta, AALH, Maceira Gonzalez, AMG, Estornell Erill, JEE, Cano Perez, OCP, Sancho-Tello, MJSTDC, Alonso Fernandez, PAF, Sepulveda Sanchez, PSS, Montero Argudo, AMA, Palombo, C, Morizzo, C, Baluci, M, Kozakova, M, Panajotu, A, Karady, J, Szeplaki, G, Horvath, T, Tarnoki, DL, Jermendy, AL, Geller, L, Merkely, B, Maurovich-Horvat, P, Group, MTA-SE "Lendület" Cardiovascular Imaging Research, Moustafa, S, Mookadam, F, Youssef, M, Zuhairy, H, Connelly, M, Prieur, T, Alvarez, N, Ashikhmin, Y, Drapkina, O, Boutsikou, M, Demerouti, E, Leontiadis, E, Petrou, E, Karatasakis, G, Kozakova, M, Morizzo, C, Bianchi, V, Marchi, B, Federico, G, Palombo, C, Chatzistamatiou, E, Moustakas, G, Memo, G, Konstantinidis, D, Mpampatzeva Vagena, I, Manakos, K, Traxanas, K, Vergi, N, Feretou, A, Kallikazaros, I, Goto, M, Uejima, T, Itatani, K, Pedrizzetti, G, Mada, RO, Daraban, AM, Duchenne, J, Voigt, JU, Chiu, D Y Y, Green, D, Johnstone, L, Sinha, S, Kalra, PA, Abidin, N, Group, Salford Vascular Research, Sikora-Frac, M, Zaborska, B, Maciejewski, P, Bednarz, B, Budaj, A, Nemes, A, Sasi, V, Gavaller, H, Kalapos, A, Domsik, P, Katona, A, Szucsborus, T, Ungi, T, Forster, T, Ungi, I, Pluchinotta, FR, Arcidiacono, C, Saracino, A, Carminati, M, Bussadori, C, Dahlslett, T, Karlsen, S, Grenne, B, Sjoli, B, Bendz, B, Skulstad, H, Smiseth, OA, Edvardsen, T, Brunvand, H, Vereckei, A, Szelenyi, ZS, Szenasi, G, Santoro, C, Galderisi, M, Niglio, T, Santoro, M, Stabile, E, Rapacciuolo, A, Spinelli, L, De Simone, G, Esposito, G, Trimarco, B, Hubert, S, Jacquier, A, Fromonot, J, Resseguier, C, Tessier, A, Guieu, R, Renard, S, Haentjiens, J, Lavoute, C, Habib, G, Menting, M E, Koopman, LP, Mcghie, JS, Rebel, B, Gnanam, D, Helbing, WA, Van Den Bosch, AE, Roos-Hesselink, JW, Shiino, K, Yamada, A, Sugimoto, K, Takada, K, Takakuwa, Y, Miyagi, M, Iwase, M, Ozaki, Y, Placido, R, Ramalho, A, Nobre E Menezes, M, Cortez-Dias, N, Goncalves, S, Guimaraes, T, Robalo Martins, S, Francisco, AR, Almeida, AG, Nunes Diogo, A, Hayashi, T, Itatani, K, Inuzuka, R, Shindo, T, Hirata, Y, Shimizu, N, Miyaji, K, Henri, C, Dulgheru, R, Magne, J, Kou, S, Davin, L, Nchimi, A, Oury, C, Pierard, L, Lancellotti, P, Kovalyova, O, Honchar, O, Tengku, WINDA, Ketaren, ANDRE, Mingo Santos, S, Monivas Palomero, V, Restrepo Cordoba, A, Rodriguez Gonzalez, E, Goirigolzarri Artaza, J, Sayago Silva, I, Garcia Lunar, I, Mitroi, C, Cavero Gibanel, M, Segovia Cubero, J, Ryu, SK, Park, JY, Kim, SH, Choi, JW, Goh, CW, Byun, YS, Choi, JH, Westholm, C, Johnson, J, Jernberg, T, Winter, R, Rio, P, Moura Branco, L, Galrinho, A, Pinto Teixeira, P, Viveiros Monteiro, A, Portugal, G, Pereira-Da-Silva, T, Afonso Nogueira, M, Abreu, J, Cruz Ferreira, R, Mazzone, A, Botto, N, Paradossi, U, Chabane, A, Francini, M, Cerone, E, Baroni, M, Maffei, S, Berti, S, Tatu-Chitoiu, G P, Deleanu, D, Macarie, C, Chioncel, O, Dorobantu, M, Udroiu, C, Calmac, L, Diaconeasa, A, Vintila, V, Vinereanu, D, investigators, RO-STEMI, Ghattas, A, Shantsila, E, Griffiths, H, Lip, GY, Galli, E, Guirette, Y, Daudin, M, Auffret, V, Mabo, P, Donal, E, Fabiani, I, Conte, L, Scatena, C, Barletta, V, Pratali, S, De Martino, A, Bortolotti, U, Naccarato, AG, Di Bello, V, Falanga, G, Alati, E, Di Giannuario, G, Zito, C, Cusma' Piccione, M, Carerj, S, Oreto, G, Dattilo, G, Alfieri, O, La Canna, G, Generati, G, Bandera, F, Pellegrino, M, Alfonzetti, E, Labate, V, Guazzi, M, Cho, EJ, Park, S-J, Lim, HJ, Yoon, HR, Chang, S-A, Lee, S-C, Park, SW, Cengiz, B, Sahin, S T, Yurdakul, S, Kahraman, S, Bozkurt, A, Aytekin, S, Borges, I P, Peixoto, ECS, Peixoto, RTS, Peixoto, RTS, Marcolla, VF, Venkateshvaran, A, Sola, S, Dash, P K, Thapa, P, Manouras, A, Winter, R, Brodin, LA, Govind, S C, Mizariene, V, Verseckaite, R, Bieseviciene, M, Karaliute, R, Jonkaitiene, R, Vaskelyte, J, Arzanauskiene, R, Janenaite, J, Jurkevicius, R, Rosner, S, Orban, M, Nadjiri, J, Lesevic, H, Hadamitzky, M, Sonne, C, Manganaro, R, Carerj, S, Cusma-Piccione, MC, Caprino, A, Boretti, I, Todaro, MC, Falanga, G, Oreto, L, D'angelo, MC, Zito, C, Le Tourneau, T, Cueff, C, Richardson, M, Hossein-Foucher, C, Fayad, G, Roussel, JC, Trochu, JN, Vincentelli, A, Obase, K, Weinert, L, Lang, R, Cavalli, G, Muraru, D, Miglioranza, MH, Addetia, K, Veronesi, F, Cucchini, U, Mihaila, S, Tadic, M, Lang, RM, Badano, L, Polizzi, V, Pino, PG, Luzi, G, Bellavia, D, Fiorilli, R, Chialastri, C, Madeo, A, Malouf, J, Buffa, V, Musumeci, F, Gripari, P, Tamborini, G, Bottari, V, Maffessanti, F, Carminati, C, Muratori, M, Vignati, C, Bartorelli, A, Alamanni, F, Pepi, M, Polymeros, S, Dimopoulos, A, Spargias, K, Karatasakis, G, Athanasopoulos, G, Pavlides, G, Dagres, N, Vavouranakis, E, Stefanadis, C, Cokkinos, DV, Pradel, S, Mohty, D, Magne, J, Darodes, N, Lavergne, D, Damy, T, Beaufort, C, Aboyans, V, Jaccard, A, Mzoughi, K, Zairi, I, Jabeur, M, Ben Moussa, F, Ben Chaabene, A, Kamoun, S, Mrabet, K, Fennira, S, Zargouni, A, Kraiem, S, Jovanova, S, Arnaudova-Dezjulovic, F, Correia, C E, Cruz, I, Marques, N, Fernandes, M, Bento, D, Moreira, D, Lopes, L, Azevedo, O, GROUP, SUNSHINE, Keramida, K, Kouris, N, Kostopoulos, V, Psarrou, G, Giannaris, V, Olympios, CD, Marketou, M, Parthenakis, F, Kalyva, N, Pontikoglou, CH, Maragkoudakis, S, Zacharis, E, Patrianakos, A, Roufas, K, Papadaki, H, Vardas, P, Dominguez Rodriguez, F, Monivas Palomero, V, Mingo Santos, S, Arribas Rivero, B, Cuenca Parra, S, Zegri Reiriz, I, Vazquez Lopez-Ibor, J, Garcia-Pavia, P, Szulik, M, Streb, W, Wozniak, A, Lenarczyk, R, Sliwinska, A, Kalarus, Z, Kukulski, T, Nemes, A, Domsik, P, Kalapos, A, Forster, T, Serra, W, Lumetti, FL, Mozzani, FM, Del Sante, GDS, Ariani, AA, Corros, C, Colunga, S, Garcia-Campos, A, Diaz, E, Martin, M, Rodriguez-Suarez, ML, Leon, V, Fidalgo, A, Moris, C, De La Hera, JM, Kylmala, M M, Rosengard-Barlund, M, Groop, P H, Lommi, J, Bruin De- Bon, HACM, Bilt Van Der, IA, Wilde, AA, Brink Van Den, RBA, Teske, AJ, Rinkel, GJ, Bouma, BJ, Teixeira, R, Monteiro, R, Garcia, J, Silva, A, Graca, M, Baptista, R, Ribeiro, M, Cardim, N, Goncalves, L, Duszanska, A, Skoczylas, I, Kukulski, T, Polonski, L, Kalarus, Z, Choi, J-H, Park, JS, Ahn, JH, Lee, JW, Ryu, SK, Ahn, J, Kim, DH, Lee, HO, Przewlocka-Kosmala, M, Mlynarczyk, J, Rojek, A, Mysiak, A, Kosmala, W, Pellissier, A, Larochelle, E, Krsticevic, L, Baron, E, Le, V, Roy, A, Deragon, A, Cote, M, Garcia, D, Tournoux, F, Yiangou, K, Azina, C, Yiangou, A, Zitti, M, Ioannides, M, Ricci, F, Dipace, G, Aquilani, R, Radico, F, Cicchitti, V, Bianco, F, Miniero, E, Petrini, F, De Caterina, R, Gallina, S, Jardim Prista Monteiro, R, Teixeira, R, Garcia, J, Baptista, R, Ribeiro, M, Cardim, N, Goncalves, L, Chung, H, Kim, JY, Joung, B, Uhm, JS, Pak, HN, Lee, MH, Lee, KY, Ragab, AM, Abdelwahab, AMIR, Yazeed, YASER, El Naggar, WAEL, Spahiu, K, Spahiu, E, Doko, A, Liesting, C, Brugts, JJ, Kofflard, MJM, Kitzen, JJEM, Boersma, E, Levin, M-D, Coppola, C, Piscopo, G, Rea, D, Maurea, C, Caronna, A, Capasso, I, Maurea, N, Azevedo, O, Tadeu, I, Lourenco, M, Portugues, J, Pereira, V, Lourenco, A, Nesukay, E, Kovalenko, V, Cherniuk, S, Danylenko, O, Muhammedov, MB, Ahmedova, DM, Hojakuliyev, BG, Atayeva, D, Nemes, A, Domsik, P, Kalapos, A, Lengyel, C, Varkonyi, TT, Orosz, A, Forster, T, Castro, M, Abecasis, J, Dores, H, Madeira, S, Horta, E, Ribeiras, R, Canada, M, Andrade, MJ, Mendes, M, Morosin, M, Piazza, R, Leonelli, V, Leiballi, E, Pecoraro, R, Cinello, M, Dell' Angela, L, Cassin, M, Sinagra, G, Nicolosi, GL, Wierzbowska-Drabik, K, Hamala, P, Kasprzak, JD, O'driscoll, J, Rossato, C, Gargallo-Fernandez, P, Araco, M, Sharma, S, Sharma, R, Jakus, N, Baricevic, Z, Ljubas Macek, J, Skoric, B, Skorak, I, Velagic, V, Separovic Hanzevacki, J, Milicic, D, Cikes, M, Deljanin Ilic, M, Ilic, S, Kocic, G, Pavlovic, R, Stoickov, V, Ilic, V, Nikolic, LJ, Generati, G, Bandera, F, Pellegrino, M, Alfonzetti, E, Labate, V, Guazzi, M, Labate, V, Bandera, F, Generati, G, Pellegrino, M, Donghi, V, Alfonzetti, E, Guazzi, M, Zakarkaite, D, Kramena, R, Aidietiene, S, Janusauskas, V, Rucinskas, K, Samalavicius, R, Norkiene, I, Speciali, G, Aidietis, A, Kemaloglu Oz, T, Ozpamuk Karadeniz, F, Akyuz, S, Unal Dayi, S, Esen Zencirci, A, Atasoy, I, Osken, A, Eren, M, Fazendas, P R, Caldeira, D, Stuart, B, Cruz, I, Rocha Lopes, L, Almeida, A R, Sousa, P, Joao, I, Cotrim, C, Pereira, H, Fazendas, P R, Caldeira, D, Stuart, B, Cruz, I, Rocha Lopes, L, Almeida, A R, Joao, I, Cotrim, C, Pereira, H, Sinem Cakal, SC, Elif Eroglu, EE, Baydar, O, Beytullah Cakal, BC, Mehmet Vefik Yazicioglu, MVY, Mustafa Bulut, MB, Cihan Dundar, CD, Kursat Tigen, KT, Birol Ozkan, BO, Ali Metin Esen, A, Yagasaki, H, Kawasaki, M, Tanaka, R, Minatoguchi, S, Houle, H, Warita, S, Ono, K, Noda, T, Watanabe, S, Minatoguchi, S, Cho, E J, Park, S J, Lim, H J, Chang, S A, Lee, S C, Park, S W, Cho, E J, Park, S J, Lim, H J, Chang, S A, Lee, S C, Park, S W, Mornos, C, Cozma, D, Ionac, A, Mornos, A, Popescu, I, Ionescu, G, Pescariu, S, Melzer, L, Faeh-Gunz, A, Seifert, B, Attenhofer Jost, C H, Storve, S, Haugen, BO, Dalen, H, Grue, JF, Samstad, S, Torp, H, Ferrarotti, L, Maggi, E, Piccinino, C, Sola, D, Pastore, F, Marino, PN, Ranjbar, S, Karvandi, M, Hassantash, SA, Karvandi, M, Ranjbar, S, Tierens, S, Remory, I, Bala, G, Gillis, K, Hernot, S, Droogmans, S, Cosyns, B, Lahoutte, T, Tran, N, Poelaert, J, Al-Mallah, M, Alsaileek, A, Nour, K, Celeng, CS, Horvath, T, Kolossvary, M, Karolyi, M, Panajotu, A, Kitslaar, P, Merkely, B, Maurovich Horvat, P, Group, MTA-SE "Lendület" Cardiovascular Imaging Research, Aguiar Rosa, S, Ramos, R, Marques, H, Portugal, G, Pereira Da Silva, T, Rio, P, Afonso Nogueira, M, Viveiros Monteiro, A, Figueiredo, L, and Cruz Ferreira, R
- Abstract
Introduction: The increase of left auricular volume (LAV) is a robust cardiovascular event predictor. Despite that echochardiography is more often used, cardiac MRI is considered more accurate. Our objetives are to validate "fast" LAV measures by MRI vs the considered gold standard (GS) and to compare Echo and MRI in a wide spectrum of patients. Methods: In a non-selected popullation with MRI study previously realized, we measured LAV by biplane method (BPMR) and by area-length in 4 chamber view (ALMR) and compared them with biplane (BPe) and discs method (MDDe) in 4 chamber view in echo. To validate MRI measurements, we measured LAV in short axis slices (Simpson Method, SM) in a group of patients and considered it the GS. Results: 186 patients were included (mean age 51 ± 17 age; 123 male; 14 in AF) with clinical indication of cardiac MRI (Philips 1,5 T). In 24 patients SM was calculated. 29% of cardiac MRI were considered normal. Mean underlying pathologies were myocardiopathy (27%), Ischemic myocardiopathy (17%), myopericarditis (10%), prior to AF ablation (4%), valvular disease (6%) and miscellaneous (7%). Excellent correlation was obtained between "fast" MRI measurements and SM in MRI (SM vs BPMR interclass correlation coefficient ICC=0.965 and SM vs ALMR, ICC=0.958; P<0.05) with low interobserver variability (ICC=0.983 for SM; ICC=0.949 for BPMR; ICC=0.931 for ALMR). "Fast" measurements by MRI showed stadistical correlation between them (CCI=0.910) (Figure). Correlation between Echo and MRI measures was only moderate. (BPRM vs BPe CCI=0,469 mean difference -30 ml; ALMR vs MDDe ICC=0,456 mean difference -24 mL). Conclusions: ‘fast’ LAV measures by MRI are comparable with the MRI GS and also between them. Echo values seem to underestimate compared to MRI, so its use may not be suitable.
- Published
- 2014
- Full Text
- View/download PDF
28. Poster session 2: Thursday 4 December 2014, 08:30-12:30 * Location: Poster area
- Author
-
Domingos, JS, Augustine, DX, Leeson, P, Noble, JA, Doan, H-L, Boubrit, L, Cheikh-Khalifa, R, Laveau, F, Djebbar, M, Pousset, F, Isnard, R, Hammoudi, N, Lisi, M, Cameli, M, Di Tommaso, C, Curci, V, Reccia, R, Maccherini, M, Henein, M Y, Mondillo, S, Leitman, M, Vered, Z, Rashid, H, Yalcin, M U, Gurses, K M, Kocyigit, D, Evranos, B, Yorgun, H, Sahiner, L, Kaya, B, Aytemir, K, Ozer, N, Bertella, E, Petulla', M, Baggiano, A, Mushtaq, S, Russo, E, Gripari, P, Innocenti, E, Andreini, D, Tondo, C, Pontone, G, Necas, J, Kovalova, S, Hristova, K, Shiue, I, Bogdanva, V, Teixido Tura, G, Sanchez, V, Rodriguez-Palomares, J, Gutierrez, L, Gonzalez-Alujas, T, Garcia-Dorado, D, Forteza, A, Evangelista, A, Timoteo, A T, Aguiar Rosa, S, Cruz Ferreira, R, Campbell, R, Carrick, D, Mccombe, C, Tzemos, N, Berry, C, Sonecki, P, Noda, M, Setoguchi, M, Ikenouchi, T, Nakamura, T, Yamamoto, Y, Murakami, T, Katou, Y, Usui, M, Ichikawa, K, Isobe, M, Kwon, BJ, Roh, JW, Kim, HY, Ihm, SH, Barron, A J, Francis, DP, Mayet, J, Wensel, R, Kosiuk, J, Dinov, B, Bollmann, A, Hindricks, G, Breithardt, OA, Rio, P, Moura Branco, L, Galrinho, A, Cacela, D, Pinto Teixeira, P, Afonso Nogueira, M, Pereira-Da-Silva, T, Abreu, J, Teresa Timoteo, A, Cruz Ferreira, R, Pavlyukova, EN, Tereshenkova, EK, Karpov, RS, Piatkowski, R, Kochanowski, J, Opolski, G, Barbier, P, Mirea, O, Guglielmo, M, Savioli, G, Cefalu, C, Pudil, R, Horakova, L, Rozloznik, M, Balestra, C, P37/03, PRVOUK, Rimbas, RC, Enescu, OA, Calin, S, Vinereanu, D, POSDRU/159/1.5/S/141531, Grant, Karsenty, C, Hascoet, S, Hadeed, K, Semet, F, Dulac, Y, Alacoque, X, Leobon, B, Acar, P, Dharma, S, Sukmawan, R, Soesanto, AM, Vebiona, KPP, Firdaus, I, Danny, SS, Driessen, M M P, Sieswerda, GTJ, Post, MC, Snijder, RJ, Van Dijk, APJ, Leiner, T, Meijboom, FJ, Chrysohoou, C, Tsitsinakis, G, Tsiachris, D, Aggelis, A, Herouvim, E, Vogiatzis, I, Pitsavos, C, Koulouris, G, Stefanadis, C, Erdei, T, Edwards, J, Braim, D, Yousef, Z, Fraser, AG, Cardiff, Investigators, MEDIA, Avenatti, E, Magnino, C, Omede', P, Presutti, D, Moretti, C, Iannaccone, A, Ravera, A, Gaita, F, Milan, A, Veglio, F, Barbier, P, Scali, MC, Simioniuc, A, Guglielmo, M, Savioli, G, Cefalu, C, Mirea, O, Fusini, L, Dini, F, Okura, H, Murata, E, Kataoka, T, Mikaelpoor, A, Ojaghi Haghighi, SH, Ojaghi Haghighi, SZ, Alizadeasl, A, Sharifi-Zarchi, A, Zaroui, A, Ben Halima, M, Mourali, MS, Mechmeche, R, Rodriguez Palomares, J F, Gutierrez, LG, Maldonado, GM, Garcia, GG, Otaegui, IO, Garcia Del Blanco, BGB, Teixido, GT, Gonzalez Alujas, MTGA, Evangelista, AE, Garcia Dorado, DGD, Godinho, A R, Correia, AS, Rangel, I, Rocha, A, Rodrigues, J, Araujo, V, Almeida, PB, Macedo, F, Maciel, MJ, Rekik, B, Mghaieth, F, Aloui, H, Boudiche, S, Jomaa, M, Ayari, J, Tabebi, N, Farhati, A, Mourali, S, Dekleva, M, Markovic-Nikolic, N, Zivkovic, M, Stankovic, A, Boljevic, D, Korac, N, Beleslin, B, Arandjelovic, A, Ostojic, M, Galli, E, Guirette, Y, Auffret, V, Daudin, M, Fournet, M, Mabo, P, Donal, E, Chin, C W L, Luo, E, Hwan, J, White, A, Newby, D, Dweck, M, Carstensen, H G, Larsen, L H, Hassager, C, Kofoed, K F, Jensen, J S, Mogelvang, R, Kowalczyk, M, Debska, M, Kolesnik, A, Dangel, J, Kawalec, W, Migliore, RA, Adaniya, ME, Barranco, MA, Miramont, G, Gonzalez, S, Tamagusuku, H, Davidsen, E S, Kuiper, K K J, Matre, K, Gerdts, E, Igual Munoz, B, Maceira Gonzalez, AMG, Erdociain Perales, MEP, Estornell Erill, JEE, Valera Martinez, FVM, Miro Palau, VMP, Piquer Gil, MPG, Sepulveda Sanchez, PSS, Cervera Zamora, ACZ, Montero Argudo, AMA, Placido, R, Silva Marques, J, Magalhaes, A, Guimaraes, T, Nobre E Menezes, M, Goncalves, S, Ramalho, A, Robalo Martins, S, Almeida, AG, Nunes Diogo, A, Abid, L, Ben Kahla, S, Charfeddine, S, Abid, D, Kammoun, S, Tounsi, A, Abid, LEILA, Abid, DORRA, Charfeddine, SALMA, Hammami, RANIA, Triki, FETEN, Akrout, MALEK, Mallek, SOUAD, Hentati, MOURAD, Kammoun, SAMIR, Sirbu, C F, Berrebi, A, Huber, A, Folliguet, T, Yang, L-T, Shih, JY, Liu, YW, Li, YH, Tsai, LM, Luo, CY, Tsai, WC, Babukov, R, Bartosh, F, Bazilev, V, Muraru, D, Cavalli, G, Addetia, K, Miglioranza, MH, Veronesi, F, Mihaila, S, Tadic, M, Cucchini, U, Badano, L, Lang, RM, Miyazaki, S, Slavich, M, Miyazaki, T, Figini, F, Lativ, A, Chieffo, A, Montrfano, M, Alfieri, O, Colombo, A, Agricola, E, Liu, D, Hu, K, Herrmann, S, Stoerk, S, Kramer, B, Ertl, G, Bijnens, B, Weidemann, F, Brand, M, Butz, T, Tzikas, S, Van Bracht, M, Roeing, J, Wennemann, R, Christ, M, Grett, M, Trappe, H-J, Scherzer, S, Geroldinger, AG, Krenn, L, Roth, C, Gangl, C, Maurer, G, Rosenhek, R, Neunteufl, T, Binder, T, Bergler-Klein, J, Martins, E, Pinho, T, Leite, S, Azevedo, O, Belo, A, Campelo, M, Amorim, S, Rocha-Goncalves, F, Goncalves, L, Silva-Cardoso, J, Ahn, HS, Kim, KT, Jeon, HK, Youn, HJ, Haland, T, Saberniak, J, Leren, IS, Edvardsen, T, Haugaa, KH, Ziolkowska, L, Boruc, A, Kowalczyk, M, Turska-Kmiec, A, Zubrzycka, M, Kawalec, W, Monivas Palomero, V, Mingo Santos, S, Goirigolzarri Artaza, J, Rodriguez Gonzalez, E, Rivero Arribas, B, Castro Urda, V, Dominguez Rodriguez, F, Mitroi, C, Gracia Lunar, I, Fernadez Lozano, I, Palecek, T, Masek, M, Kuchynka, P, Fikrle, M, Spicka, I, Rysava, R, Linhart, A, Saberniak, J, Hasselberg, NE, Leren, IS, Haland, T, Borgquist, R, Platonov, PG, Edvardsen, T, Haugaa, KH, Ancona, R, Comenale Pinto, S, Caso, P, Coopola, MG, Arenga, F, Rapisarda, O, D'onofrio, A, Sellitto, V, Calabro, R, Rosca, M, Popescu, BA, Calin, A, Mateescu, A, Beladan, CC, Jalba, M, Rusu, E, Zilisteanu, D, Ginghina, C, Pressman, G, Cepeda-Valery, B, Romero-Corral, A, Moldovan, R, Saenz, A, Orban, M, Samuel, SP, Fijalkowski, M, Fijalkowska, M, Gilis-Siek, N, Blaut, K, Galaska, R, Sworczak, K, Gruchala, M, Fijalkowski, M, Nowak, R, Gilis-Siek, N, Fijalkowska, M, Galaska, R, Gruchala, M, Ikonomidis, I, Triantafyllidi, H, Trivilou, P, Tzortzis, S, Papadopoulos, C, Pavlidis, G, Paraskevaidis, I, Lekakis, J, Padiyath, A, Li, L, Xiao, Y, Danford, DA, Kutty, S, Kaymaz, C, Aktemur, T, Poci, N, Ozturk, S, Akbal, O, Yilmaz, F, Tokgoz Demircan, HC, Kirca, N, Tanboga, IH, Ozdemir, N, Investigators, EUPHRATES, Greiner, S, Jud, A, Aurich, M, Hess, A, Hilbel, T, Hardt, S, Katus, HA, D'ascenzi, F, Cameli, M, Alvino, F, Lisi, M, Focardi, M, Solari, M, Bonifazi, M, Mondillo, S, Konopka, M, Krol, W, Klusiewicz, A, Burkhard, K, Chwalbinska, J, Pokrywka, A, Dluzniewski, M, Braksator, W, King, G J, Coen, K, Gannon, S, Fahy, N, Kindler, H, Clarke, J, Iliuta, L, Rac-Albu, M, Placido, R, Robalo Martins, S, Guimaraes, T, Nobre E Menezes, M, Cortez-Dias, N, Francisco, A, Silva, G, Goncalves, S, Almeida, AG, Nunes Diogo, A, Kyu, K, Kong, WKF, Songco, GG, Galupo, MJ, Castro, MD, Shin Hnin, W, Ronald Lee, CH, Poh, KK, Milazzo, V, Di Stefano, C, Tosello, F, Leone, D, Ravera, A, Sabia, L, Sobrero, G, Maule, S, Veglio, F, Milan, A, Jamiel, A M, Ahmed, A M, Farah, I, Al-Mallah, M H, Petroni, R, Magnano, R, Bencivenga, S, Di Mauro, M, Petroni, S, Altorio, SF, Romano, S, Penco, M, Kumor, M, Lipczynska, M, Klisiewicz, A, Wojcik, A, Konka, M, Kozuch, K, Szymanski, P, Hoffman, P, Rimbas, RC, Rimbas, M, Enescu, OA, Mihaila, S, Calin, S, Vinereanu, D, 112/2011, Grant CNCSIS, 159/1.5/S/141531, Grant POSDRU, Donal, E, Reynaud, A, Lund, LH, Persson, H, Hage, C, Oger, E, Linde, C, Daubert, JC, investigators, KaRen, Maria Oliveira Lima, M, Costa, H, Gomes Da Silva, M, Noman Alencar, MC, Carmo Pereira Nunes, M, Costa Rocha, MO, Abid, L, Charfeddine, S, Ben Kahla, S, Abid, D, Siala, A, Hentati, M, Kammoun, S, Kovalova, S, Necas, J, Ozawa, K, Funabashi, N, Takaoka, H, Kobayashi, Y, Matsumura, Y, Wada, M, Hirakawa, D, Yasuoka, Y, Morimoto, N, Takeuchi, H, Kitaoka, H, Sugiura, T, Lakkas, L, Naka, KK, Ntounousi, E, Gkirdis, I, Koutlas, V, Bechlioulis, A, Pappas, K, Katsouras, CS, Siamopoulos, K, Michalis, LK, Naka, KK, Evangelou, D, Kalaitzidis, R, Bechlioulis, A, Lakkas, L, Gkirdis, I, Tzeltzes, G, Nakas, G, Katsouras, CS, Michalis, LK, Generati, G, Bandera, F, Pellegrino, M, Labate, V, Alfonzetti, E, Guazzi, M, Zagatina, A, Zhuravskaya, N, Al-Mallah, M, Alsaileek, A, Qureshi, W, Karsenty, C, Hascoet, S, Peyre, M, Hadeed, K, Alacoque, X, Amadieu, R, Leobon, B, Dulac, Y, Acar, P, Yamanaka, Y, Sotomi, Y, Iwakura, K, Inoue, K, Toyoshima, Y, Tanaka, K, Oka, T, Tanaka, N, Orihara, Y, Fujii, K, Soulat-Dufour, L, Lang, S, Boyer-Chatenet, L, Van Der Vynckt, C, Ederhy, S, Adavane, S, Haddour, N, Boccara, F, Cohen, A, Huitema, MP, Boerman, S, Vorselaars, VMM, Grutters, JC, Post, MC, Gopal, A S, Saha, SK, Toole, RS, Kiotsekoglou, A, Cao, JJ, Reichek, N, Meyer, C G, Altiok, E, Al Ateah, G, Lehrke, M, Becker, M, Lotfi, S, Autschbach, R, Marx, N, Hoffmann, R, Frick, M, Nemes, A, Sepp, R, Kalapos, A, Domsik, P, Forster, T, Caro Codon, J, Blazquez Bermejo, Z, Lopez Fernandez, T, Valbuena Lopez, S C, Iniesta Manjavacas, A M, De Torres Alba, F, Dominguez Melcon, F, Pena Conde, L, Moreno Yanguela, M, Lopez-Sendon, J L, Nemes, A, Lengyel, C, Domsik, P, Kalapos, A, Orosz, A, Varkonyi, TT, Forster, T, Rendon, J, Saldarriaga, C I, Duarte, N, Nemes, A, Domsik, P, Kalapos, A, Forster, T, Nemes, A, Domsik, P, Kalapos, A, Sepp, R, Foldeak, D, Borbenyi, Z, Forster, T, Hamdy, AM, Fereig, HM, Nabih, MA, Abdel-Aziz, A, Ali, AA, Broyd, CJ, Wielandts, J-Y, De Buck, S, Michielsen, K, Louw, R, Garweg, C, Nuyts, J, Ector, J, Maes, F, Heidbuchel, H, Gillis, K, Bala, G, Tierens, S, Cosyns, B, Maurovich-Horvat, P, Horvath, T, Jermendy, A, Celeng, C, Panajotu, A, Bartykowszki, A, Karolyi, M, Tarnoki, AD, Jermendy, G, and Merkely, B
- Abstract
Purpose: 3D echocardiography (3DE) enables fast 3D acquisition but subsequent manual navigation to find 2D diagnostic planes can be time consuming. We have developed and validated an automated machine learning-based technique to find apical 2-, 3- and 4-chamber (A2C, A3C, A4C) views that enables fast volume navigation and analysis. Methods: 3DE volumes were acquired (Philips iE33: X3-1 and X5-1 probes) from 30 healthy volunteers and 36 clinical patients with suspected valve disease and coronary heart disease. 66 end diastolic volumes were used to assess the accuracy of apical standard view finding by our method against manual plane finding. To do this, dedicated software was developed with a machine learning approach and a 3-fold cross validation of results was performed. Results: Automatic A4C view detection was possible in 60/66 (91%) of volumes; detection failures were due to suboptimal myocardium wall integrity or lack of right ventricle in the scan. A2C and A3C views were extracted from the A4C view using the known geometrical relationships between apical standard views (A2C to A3C: 30°~40° and A2C to A4C: 90° of rotation over the left ventricle long axis, as shown in the Figure). In average, our method accurately found the heart apex and mitral valve centre with a 7.1 ± 5.7 mm and 7.2 ± 5.3 mm error, respectively. Conclusions: In order to automate clinical workflow, we have developed a new and fully automatic machine learning strategy for apical standard view finding which performed well (91% detection accuracy) on volunteer and clinical 3D echocardiograms.
Figure - Published
- 2014
- Full Text
- View/download PDF
29. Club 35 Moderated Poster session: Wednesday 3 December 2014, 09:00-16:00 * Location: Moderated Poster area
- Author
-
Mihaila, S, Aruta, P, Muraru, D, Miglioranza, M, Cavalli, G, Piasentini, E, Iliceto, S, Vinereanu, D, Badano, LP, Ren, B, Mulder, HW, Haak, A, Mcghie, J, Szili-Torok, T, Nieman, K, Van Stralen, M, Pluim, JPW, Geleijnse, ML, Bosch, JG, Lervik Nilsen, L C, Brekke, B, Missant, C, Haemers, P, Tong, L, Ortega, A, Sutherland, G, D'hooge, J, Stoylen, A, Assabiny, A, Kovacs, A, Faludi, M, Tapolyai, M, Berta, K, Apor, A, Merkely, B, Ren, B, Kirschbaum, S, Vletter, W, Houtgraaf, J, Geleijnse, M, Teixeira, R, Monteiro, R, Garcia, J, Silva, A, Graca, M, Baptista, R, Ribeiro, M, Cardim, N, Goncalves, L, Miglioranza, MH, Mihaila, S, Muraru, D, Cucchini, U, Cavalli, G, Cecchetto, A, Romeo, G, Iliceto, S, Badano, LP, Hamed, W, Badran, HMB, Noamany, MFN, Ahmed, NFA, Elsedi, MSE, Yacoub, MY, Castaldi, B, Vida, V, Daniels, Q, Reffo, E, Crepaz, R, Maschietto, N, Campagnano, E, Padalino, M, Stellin, G, Milanesi, O, Galli, E, Guirette, Y, Auffret, V, and Mabo, P
- Abstract
Background: Mitral annulus (MA) remodeling was suggested to have a role in the occurrence of mitral valve (MV) leaflet flail in pts with organic mitral regurgitation (OMR). Aim: To assess the extent of MA remodeling and dysfunction in relation to the severity of MV disease in pts with OMR. Methods: We acquired 3D full-volumes of the MA and left ventricle (LV) in 52 pts (57 ± 15 yrs, 34 men) with OMR (40 pts with posterior mitral prolapse, 12 pts with Barlow disease), and in sinus rhythm. MV morphology was assessed using both en-face view of volume rendered images and longitudinal slices of the datasets. MA size and function were automatically assessed during cardiac systole (MV assessment 2.3, TomTec). LV volumes and ejection fraction (LVEF) were measured with AutoLVQ (Echopac BT 12, GE). Results: 14 pts showed a flail of the MV, and 38 pts MV prolapse without flail. LVEF, MA displacement and MA size and geometry were similar in pts with and without MV flail (Table). Conversely, MA fractional area change was significantly decreased in pts with leaflet flail. Binary logistic regression showed that decreased MA fractional area change was associated with the presence of leaflet flail (β=0.20, p=0.02). Conclusions: In pts with OMR and normal LV function, the contractile dysfunction of the MA, and not the size of the MA, is associated with the presence of leaflet flail. Further studies are needed to assess if the MA contractile dysfunction precedes or is a consequence of the occurrence of MV flail.
MA parameters MVP with flail N=14 MVP without flail N=38 p Antero-posterior diameter (cm) 3.6 ± 0.6 3.4 ± 0.6 0.274 Anterolateral-posteromedial diameter (cm) 4.6 ± 0.7 4.6 ± 0.7 0.946 MA area (cm2) 13.8 ± 3.8 12.9 ± 4.1 0.458 MA circumference (cm) 13.5 ± 2.0 13.0 ± 2.0 0.464 Anterior leaflet area (cm2) 6.3 ± 2.2 6.5 ± 2.3 0.485 Posterior leaflet area (cm2) 9.1 ± 2.4 7.5 ± 2.9 0.063 Sphericity Index 0.8 ± 0.08 0.75 ± 0.07 0.051 Non-planarity angle (0) 150 ± 12 155 ± 11 0.190 MA height (mm) 6.0 ± 0.2 5.4 ± 0.2 0.297 MA fractional area change (%) 19 ± 3 23 ± 6 0.015* MA displacement (mm) 10.6 ± 2.6 9.5 ± 3.3 0.237 - Published
- 2014
- Full Text
- View/download PDF
30. Poster session 4: Friday 5 December 2014, 08:30-12:30 * Location: Poster area
- Author
-
Orii, M, Tanimoto, T, Yokoyama, M, Ota, S, Kubo, T, Hirata, K, Tanaka, A, Imanishi, T, Akasaka, T, Michelsen, MM, Pena, A, Mygind, ND, Hoest, NB, Prescott, E, Abd El Dayem, SOHA, Battah, AHMED, Abd El Azzez, FATEN, Ahmed, AZZA, Fattoh, AYA, Ismail, REEM, Andjelkovic, K, Kalimanovska Ostric, D, Nedeljkovic, I, Andjelkovic, I, Rashid, HESHAM, Abuel Enien, HESHAM, Ibraheem, MAHER, work, Tissue Doppler echocardiography research, Vago, H, Toth, A, Csecs, I, Czimbalmos, CS, Suhai, F I, Kecskes, K, Becker, D, Simor, T, Merkely, B, D'ascenzi, F, Pelliccia, A, Natali, BM, Cameli, M, Lisi, M, Focardi, M, Corrado, D, Bonifazi, M, Mondillo, S, Zaha, VG, Kim, GE, Su, KN, Zhang, J, Mikush, N, Ross, J, Palmeri, M, Young, LH, Tadic, M, Ilic, SI, Celic, VC, Jaimes, C, Gonzalez Mirelis, J, Gallego, M, Goirigolzarri, J, Pellegrinet, M, Poli, S, Prati, G, Vriz, O, Di Bello, V, Carerj, S, Zito, C, Mateescu, A, Popescu, BA, Antonini-Canterin, F, Chatzistamatiou, E, Moustakas, G, Memo, G, Konstantinidis, D, Mpampatzeva Vagena, I, Manakos, K, Traxanas, K, Vergi, N, Feretou, A, Kallikazaros, I, Hewing, B, Theres, L, Dreger, H, Spethmann, S, Stangl, K, Baumann, G, Knebel, F, Uejima, T, Itatani, K, Nakatani, S, Lancellotti, P, Seo, Y, Zamorano, JL, Ohte, N, Takenaka, K, group, VFM international collaboration, Naar, J, Mortensen, L, Johnson, J, Winter, R, Shahgaldi, K, Manouras, A, Braunschweig, F, Stahlberg, M, Coisne, D, Al Arnaout, A-M, Tchepkou, C, Raud Raynier, P, Diakov, C, Degand, B, Christiaens, L, Barbier, P, Mirea, O, Cefalu, C, Savioli, G, Guglielmo, M, Maltagliati, A, O'neill, L, Walsh, K, Hogan, J, Manzoor, T, Ahern, B, Owens, P, Savioli, G, Guglielmo, M, Mirea, O, Cefalu, C, Barbier, P, Sengelov, M, Biering-Sorensen, T, Jorgensen, PG, Bruun, NE, Fritz-Hansen, T, Bech, J, Olsen, FJ, Sivertsen, J, Jensen, JS, Marta, L, Abecasis, J, Reis, C, Ribeiras, R, Andrade, MJ, Mendes, M, D'andrea, A, Stanziola, A, Di Palma, E, Martino, M, Lanza, M, Betancourt, V, Maglione, M, Calabro', R, Russo, MG, Bossone, E, Vogt, M O, Meierhofer, CH, Rutz, TH, Fratz, S, Ewert, P, Roehlig, CH, Kuehn, A, Storsten, P, Eriksen, M, Remme, EW, Boe, E, Smiseth, OA, Skulstad, H, Ereminiene, E, Ordiene, R, Ivanauskas, V, Vaskelyte, J, Stoskute, N, Kazakauskaite, E, Benetis, R, Marketou, M, Parthenakis, F, Kontaraki, J, Zacharis, E, Maragkoudakis, S, Logakis, J, Roufas, K, Vougia, D, Vardas, P, Dado, E, Dado, E, Knuti, G, Djamandi, J, Shota, E, Sharka, I, Saka, J, Halmai, L, Nemes, A, Kardos, A, Neubauer, S, Kurnicka, K, Domienik-Karlowicz, J, Lichodziejewska, B, Goliszek, S, Grudzka, K, Krupa, M, Dzikowska-Diduch, O, Ciurzynski, M, Pruszczyk, P, Chung, H, Kim, JY, Yoon, YW, Min, PK, Lee, BK, Hong, BK, Rim, SJ, Kwon, HM, Choi, EY, Soya, OV, Kuryata, OV, Kakihara, R, Naruse, C, Inayoshi, A, El Sebaie, MAHA, Frer, ABDEL, Abdelsamie, MAGDY, Eldamanhory, AHMED, Ciampi, Q, Cortigiani, L, Simioniuc, A, Manicardi, C, Villari, B, Picano, E, Sicari, R, Ferferieva, V, Deluyker, D, Lambrichts, I, Rigo, JM, Bito, V, Kuznetsov, VA, Yaroslavskaya, EI, Krinochkin, DV, Pushkarev, GS, Gorbatenko, EA, Trzcinski, P, Michalski, BW, Lipiec, P, Szymczyk, E, Peczek, L, Nawrot, B, Chrzanowski, L, Kasprzak, JD, Todaro, MC, Zito, C, Khandheria, BK, Cusma-Piccione, M, La Carrubba, S, Antonini-Canterin, F, Di Bello, V, Oreto, G, Di Bella, G, Carerj, S, Gunyeli, E, Oliveira Da Silva, C, Sahlen, A, Manouras, A, Winter, R, Shahgaldi, K, Spampinato, RA, Tasca, M, Roche E Silva, JG, Strotdrees, E, Schloma, V, Dmitrieva, Y, Dobrovie, M, Borger, MA, Mohr, FW, Einarsen, E, Cramariuc, D, Lonnebakken, MT, Boman, K, Gohlke-Barwolf, C, Chambers, JB, Gerdts, E, Calin, A, Rosca, M, Beladan, CC, Mirescu Craciun, A, Gurzun, MM, Mateescu, A, Enache, R, Ginghina, C, Popescu, BA, Antova, E, Georgievska Ismail, LJ, Srbinovska, E, Andova, V, Peovska, I, Davceva, J, Otljanska, M, Vavulkis, M, Tsuruta, H, Kohsaka, S, Murata, M, Yasuda, R, Dan, M, Yashima, F, Inohara, T, Maekawa, Y, Hayashida, K, Fukuda, K, Migliore, R, Adaniya, ME, Barranco, MA, Miramont, G, Gonzalez, S, Tamagusuku, H, Abid, L, Ben Kahla, S, Charfeddine, S, Abid, D, Kammoun, S, Amano, M, Izumi, C, Miyake, M, Tamura, T, Kondo, H, Kaitani, K, Nakagawa, Y, Ghulam Ali, S, Fusini, L, Tamborini, G, Muratori, M, Gripari, P, Bottari, V, Celeste, F, Cefalu', C, Alamanni, F, Pepi, M, Obase, K, Mor-Avi, V, Weinert, L, Lang, R, Teixeira, R, Monteiro, R, Garcia, J, Ribeiro, M, Cardim, N, Goncalves, L, Miglioranza, MH, Muraru, D, Cavalli, G, Addetia, K, Cucchini, U, Mihaila, S, Tadic, M, Veronesi, F, Lang, RM, Badano, L, Galian Gay, L, Gonzalez Alujas, MT, Teixido Tura, G, Gutierrez Garcia, L, Rodriguez-Palomares, JF, Evangelista Masip, A, Conte, L, Fabiani, I, Giannini, C, La Carruba, S, De Carlo, M, Barletta, V, Petronio, AS, Di Bello, V, Mahmoud, H, Al-Ghamdi, M, Ghabashi, A, Salaun, E, Zenses, AS, Evin, M, Collart, F, Pibarot, P, Habib, G, Rieu, R, Fabregat Andres, O, Estornell Erill, J, Cubillos-Arango, A, Bochard-Villanueva, B, Chacon-Hernandez, N, Higueras-Ortega, L, Perez-Bosca, L, Paya-Serrano, R, Ridocci-Soriano, F, Cortijo-Gimeno, J, Mzoughi, K, Zairi, I, Jabeur, M, Ben Moussa, F, Mrabet, K, Kamoun, S, Fennira, S, Ben Chaabene, A, Kraiem, S, Schnell, F, Betancur, J, Daudin, M, Simon, A, Lentz, PA, Tavard, F, Hernandes, A, Carre, F, Garreau, M, Donal, E, Abduch, MCD, Vieira, MLC, Antunes, M, Mathias, W, Mady, C, Arteaga, E, Alencar, AM, Tesic, M, Djordjevic-Dikic, A, Beleslin, B, Giga, V, Trifunovic, D, Petrovic, O, Jovanovic, I, Petrovic, M, Stepanovic, J, Vujisic-Tesic, B, Choi, EY, Cha, JJ, Chung, H, Kim, KH, Yoon, YW, Kim, JY, Lee, BK, Hong, BK, Rim, SJ, Kwon, HM, Bergler-Klein, J, Geier, C, Maurer, G, Gyongyosi, M, Cortes Garcia, M, Oliva, MR, Navas, MA, Orejas, M, Rabago, R, Martinez, ME, Briongos, S, Romero, AM, Rey, M, Farre, J, Ruisanchez Villar, C, Ruiz Guerrero, L, Rubio Ruiz, S, Lerena Saenz, P, Gonzalez Vilchez, FJ, Hernandez Hernandez, JL, Armesto Alonso, S, Blanco Alonso, R, Martin Duran, R, Gonzalez-Gay, MA, Novo, G, Marturana, I, Bonomo, V, Arvigo, L, Evola, V, Karfakis, G, Lo Presti, M, Verga, S, Novo, S, Petroni, R, Acitelli, A, Bencivenga, S, Cicconetti, M, Di Mauro, M, Petroni, A, Romano, S, Penco, M, Park, SM, Kim, SA, Kim, MN, Shim, WJ, Tadic, M, Majstorovic, AM, Ivanovic, BI, Celic, VC, Driessen, M M P, Meijboom, FJ, Mertens, L, Dragulescu, A, Friedberg, MK, De Stefano, F, Santoro, C, Buonauro, A, Muscariello, R, Lo Iudice, F, Ierano, P, Esposito, R, Galderisi, M, Sunbul, M, Kivrak, T, Durmus, E, Yildizeli, B, Mutlu, B, Rodrigues, AC, Daminello, E, Echenique, LS, Cordovil, A, Oliveira, W, Monaco, CH, Lira, E, Fischer, CH, Vieira, M, Morhy, S, Mignot, A, Jaussaud, J, Chevalier, L, Lafitte, S, D'ascenzi, F, Cameli, M, Curci, V, Alvino, F, Lisi, M, Focardi, M, Corrado, D, Bonifazi, M, Mondillo, S, Ikonomidis, I, Pavlidis, G, Lambadiari, V, Kousathana, F, Triantafyllidi, H, Varoudi, M, Dimitriadis, G, Lekakis, J, Cho, J S, Cho, EJ, Yoon, HJ, Ihm, SH, Lee, JH, Molnar, A A, Kovacs, A, Apor, A, Tarnoki, AD, Tarnoki, DL, Horvath, T, Maurovich-Horvat, P, Jermendy, GY, Kiss, RG, Merkely, B, Al-Habbaa, A, Petrovic-Nagorni, S, Ciric-Zdravkovic, S, Stanojevic, D, Jankovic-Tomasevic, R, Atanaskovic, V, Mitic, V, Todorovic, L, Dakic, S, Park, J S, Choi, JH, Kim, SH, Choi, JH, Kwon, YS, Jin, HY, Coppola, C, Piscopo, G, Galletta, F, Maurea, C, Esposito, E, Barbieri, A, Maurea, N, Kaldararova, M, Tittel, P, Kantorova, A, Vrsanska, V, Kollarova, E, Hraska, V, Nosal, M, Ondriska, M, Masura, J, Simkova, I, Tadeu, I, Azevedo, O, Lourenco, M, Luis, F, Lourenco, A, Planinc, i, Bagadur, G, Bijnens, B, Ljubas, J, Baricevic, Z, Skoric, B, Velagic, V, Milicic, D, Cikes, M, Campanale, C M, Di Maria, S, Mega, S, Nusca, A, Marullo, F, Di Sciascio, G, El Tahlawi, M, Abdallah, M, Gouda, M, Gad, MARWA, Elawady, M, Igual Munoz, B, Maceira Gonzalez Alicia, AMG, Estornell Erill, JEE, Donate Betolin, LDB, Vazquez Sanchez Alejandro, AVS, Valera Martinez, FVM, Sepulveda- Sanchez, PSS, Cervera Zamora, ACZ, Piquer Gil Marina, MPG, Montero- Argudo, AMA, Naka, KK, Evangelou, D, Lakkas, L, Kalaitzidis, R, Bechlioulis, A, Gkirdis, I, Tzeltzes, G, Nakas, G, Pappas, K, Michalis, LK, Mansencal, N, Bagate, F, Arslan, M, Siam-Tsieu, V, Deblaise, J, El Mahmoud, R, Dubourg, O, Wierzbowska-Drabik, K, Plewka, M, Kasprzak, JD, Bandera, F, Generati, G, Pellegrino, M, Alfonzetti, E, Labate, V, Villani, S, Gaeta, M, Guazzi, M, Bandera, F, Generati, G, Pellegrino, M, Labate, V, Alfonzetti, E, Guazzi, M, Generati, G, Bandera, F, Pellegrino, M, Labate, V, Alfonzetti, E, Guazzi, M, Grycewicz, T, Szymanska, K, Grabowicz, W, Lubinski, A, Sotaquira, M, Pepi, M, Tamborini, G, Caiani, EG, Bochard Villanueva, B, Chacon-Hernandez, N, Fabregat-Andres, O, Garcia-Gonzalez, P, Cubillos-Arango, A, De La Espriella-Juan, R, Albiach-Montanana, C, Berenguer-Jofresa, A, Perez-Bosca, JL, Paya-Serrano, R, Cheng, H-L, Huang, C-H, Wang, Y-C, Chou, W-H, Kuznetsov, VA, Melnikov, NN, Krinochkin, DV, Kolunin, GV, Enina, TN, Sierraalta, W, Le Bihan, D, Barretto, RBM, Assef, JE, Gospos, M, Buffon, M, Ramos, AIO, Garcia, A, Pinto, IMF, Souza, AGMR, Mueller, H, Reverdin, S, Ehret, G, Conti, L, Dos Santos, S, Abdel Moneim, S S, Nhola, L F, Huang, R, Kohli, M, Longenbach, S, Green, M, Villarraga, H R, Bordun, K A, Jassal, D S, Mulvagh, S L, Evangelista, A, Madeo, A, Piras, P, Giordano, F, Giura, G, Teresi, L, Gabriele, S, Re, F, Puddu, P, Torromeo, C, Suwannaphong, S, Vathesatogkit, P, See, O, Yamwong, S, Katekao, W, Sritara, P, Iliuta, L, Szulik, M, Streb, W, Wozniak, A, Lenarczyk, R, Sliwinska, A, Kalarus, Z, Kukulski, T, Weng, K-P, Lin, C-C, Hein, S, Lehmann, L, Kossack, M, Juergensen, L, Katus, HA, Hassel, D, Turrini, F, Scarlini, S, Giovanardi, P, Messora, R, Mannucci, C, Bondi, M, Olander, R, Sundholm, JKM, Ojala, TH, Andersson, S, Sarkola, T, Karolyi, M, Kocsmar, I, Raaijmakers, R, Kitslaar, PH, Horvath, T, Szilveszter, B, Merkely, B, Maurovich-Horvat, P, Heart, Center, Vascular, University, Semmelweis, Budapest, Hungary, and Group, MTA-SE Lendület Cardiovascular Imaging Research
- Abstract
Purpose: Although delayed-enhancement magnetic resonance imaging (DEMRI) is essential for diagnosis of cardiac sarcoidosis (CS), the test was not available when pacemaker was implamted. Recently, MR-conditional pacemaker has become avilable and we hypothesized that this device would be useful for diagnosis and management of CS. The aim of this study was to assess the diagnostic ability of MR-conditional pacemaker about CS in patients with advanced A-V nodal block (AAVB). Methods: Twenty-seven AAVB patients (14 men, 13 women; mean age, 69 ± 11 years) who were implanted MR-conditional pacemaker were studied. DEMRI was performed 6 weeks after implantation of permanent pacemaker. In patients with positive for DE, additional examinations like echocardiography, radioisotope imaging, biopsy, and coronary computed-tomography were performed due to confirm the diagnosis of CS and exclude coronary artery disease. Results: DE was observed in 12 patients (44 %). Out of 12 patients, 2 patients were excluded for having prior myocardial infarction. Seven of 10 (70 %) patients were diagnosed of CS by the consensus criteria. Compared with non-CS group, CS group had significantly lower age (61 ± 12 years vs. 72 ± 9 years p = 0.017). There was no significant difference about sex, angiotensin-converting enzyme, brain natriuretic peptide, and left ventricular ejection fraction between 2 groups. Six patients had started corticosteroid therapy and 5 patients (83%) recovered A-V nodal conduction. Conclusion: MR-conditional pacemaker was useful for diagnosis and management of patients with AAVB caused by CS.
Figure Cardiac MRI in patient with AV block - Published
- 2014
- Full Text
- View/download PDF
31. Club 35 Poster session 1: Wednesday 3 December 2014, 09:00-16:00 * Location: Poster area
- Author
-
Krestjyaninov, MV, Gimaev, RH, Razin, VA, Halaph, H, Shameeva, OV, Galli, E, Oger, E, Levery, M, Mabo, P, Donal, E, Rodriguez Munoz, D, Carbonell Sanroman, A, Moya Mur, JL, Lazaro Rivera, C, Fernandez Santos, S, Rincon Diaz, LM, Casas Rojo, E, Jimenez Nacher, JJ, Fernandez-Golfin, C, Zamorano Gomez, JL, Shamsheva, D, Zaletova, T, Parkhomenko, O, Bogdanov, A, Simova, I, Katova, T, Galderisi, M, Pauncheva, B, Ozawa, K, Funabashi, N, Takaoka, H, Kobayashi, Y, Titov, I, Kovalenko, V, Nesukay, E, Danylenko, O, Polenova, N, Moatemri, F, Messaoudi, Y, Mahdhaoui, A, Bouraoui, H, Hajri, S, Jeridi, G, Danylenko, O, Kovalenko, V, Nesukay, E, Polenova, N, Titov, I, Souza, C, Nascimento, CAS, Cordovil, IP, Belem, LJH, Horcades, RF, Sahate, AS, Pereira, SB, Benchimol-Barbosa, PR, Barros, CN, Weitzel, LH, Altin, C, Sade, LE, Gezmis, E, Ozen, N, Muderrisoglu, H, Voilliot, D, Magne, JM, Dulgheru, RD, Kou, SK, Henri, CH, Caballero, LC, De Sousa, CDS, Sprynger, MS, Pierard, LP, Lancellotti, PL, Miglioranza, MH, Mihaila, S, Muraru, D, Cucchini, U, Cecchetto, A, Cavalli, G, Romeo, G, Iliceto, S, Badano, LP, Brecht, A, Wageloehner, T, Oertelt-Prigione, S, Seeland, U, Ruecke, M, Baumann, G, Regitz-Zagrosek, V, Stangl, V, Knebel, F, Investigators, BEFRI, Khanna, R, Raghuwanshi, A, Kapoor, A, Tewari, S, Garg, N, Kumar, S, Goel, PK, Altin, C, Sade, LE, Gezmis, E, Ozen, N, Duzceker, O, Muderrisoglu, H, Petre, I, Tautu, OF, Onciul, S, Iancovici, S, Zamfir, D, Onut, R, Dorobantu, M, Jashari, F, Ibrahimi, P, Johansson, E, Gronlund, C, Bajraktari, G, Wester, P, Henein, MY, Torbas, O, Sirenko, YU, Radchenko, G, Page, M, Gerber, BL, Pasquet, A, Pouleur, AC, Vancreynest, D, Vanoverschelde, JL, Wieczorek, J, Wieczorek, P, Mizia, M, Gieszczyk-Strozik, K, Sikora-Puz, A, Lasota, B, Mizia-Stec, K, Coisne, A, Levy, F, Malaquin, D, Richardson, M, Quere, JP, Montaigne, D, Tribouilloy, C, Teixeira, R, Monteiro, R, Barbosa, A, Batista, R, Ribeiro, M, Cardim, N, Goncalves, L, Miskowiec, D, Wierzbowska-Drabik, K, Wejner-Mik, P, Michalski, B, Wdowiak-Okrojek, K, Szymczyk, E, Kasprzak, JD, Lipiec, P, Grossi, F, Oddo, A, Pieri, F, Cordisco, A, Zucchini, M, Mori, F, and Gensini, GF
- Abstract
Left ventricle hypertrophy (LVH) is strongly associated with stroke and myocardial infarction in hypertensive patients. Hypertensive heart characterized by cardiomyocytes hypertrophy, fibroblasts proliferation, enlargement of interstitial collagen volume and their ratio disorders which result in dangerous complications. Renin-angiotensin-aldosterone system (RAAS) and insulin-like growth factor 1 (IGF-1) play significant role in development of myocardial fibrosis and LV remodelling in hypertensive patients. The purpose of the study is to evaluate relations between activity of RAAS and interstitial fibrosis markers and left ventricle geometry models in hypertensive patients. Were examined 286 patients (both men and women) with Hypertension 2-3 grade and stable ischemic heart disease 2-3 functional class complicated by chronic heart failure I-III NYHA functional class. The mean age of patients 53 (3.7) years. Patients with arrhythmias, diabetes mellitus were excluded from the study. In all patients was performed EchoCG (ASE/EAE recommendations 2005) and were evaluated plasma levels of aldosteron, angiotensin 2, angiotensin-converting enzyme (ACE), tissue inhibitor of metalloproteinases-1 (TIMP-1), IGF-1. HF NYHA functional class was determined by using the 6MWT. Statistical significance was defined at the level of methods for p<0,05. Results of the study are shown in Table 1. Thus, the results of the study show that interstitial myocardium fibrosis and activity of RAAS were significantly higher in patients with concentric hypertrophy and eccentric hypertrophy.
LV remodelling, RAAS and fibrosis Parameters LV geometry model Normal geometry Concentric remodelling Eccentric hypertrophy Concentric hypertrophy n=148 n=36 n=50 n=52 Angiothensin 2, pg/ml 37.8 (11.6) 39.0 (16.4) 47.4 (13.4) 57.7 (10.5)*† ACE, u/l 45.8 (16.7) 38.9 (17.1) 62.5 (35.3)* 73.8 (25.9)* Aldosterone, pg/ml 121.5 (27.5) 95.8 (43.4) 144.5 (38.3)* 143.2 (38.9)* TIMP-1, ng/ml 276.9 (80.3) 249.8 (83.2) 359.9 (119.5)*‡ 403.1 (128.5)*‡ IGF-1, ng/ml 162.6 (23.6)† 158.3 (18.9)† 139.9 (19.7) 155.5 (24.5)† Interstitial collagen volume fraction, % 3.03 (0.78) 3.66 (0.96)* 4.47 (0.98)*‡ 5.34 (0.97)*†‡ *- p<0.05 in comparison with patients with normal geometry; † - p<0.05 in comparison with patients with eccentric hypertrophy; ‡ - p<0.05 in comparison with patients with concentric remodelling. Results are shown in M (SD). - Published
- 2014
- Full Text
- View/download PDF
32. Club 35 Moderated Poster Session - Part B: 11/12/2013, 09:30-16:00 * Location: Moderated Poster area
- Author
-
Tuluce, Kamil, Yakar Tuluce, Selcen, Isayev, Elnur, Bilgin, Murat, Yavuzgil, Oguz, Gurgun, Cemil, Nalbantgil, Sanem, Soydas Cinar, Cahide, Ozerkan, Filiz, Brandao Da Silva, D, Lehmann, R, Prinz, C, Horstkotte, D, Faber, L, Assabiny, A, Apor, A, Nagy, A, Vago, H, Toth, A, Merkely, B, Kovacs, A, Miglioranza, MH, Muraru, D, Peluso, D, Cucchini, U, Mihaila, S, Naso, P, Puma, L, Kocabay, G, Iliceto, S, Badano, LP, Marek, J, Ahmed, M, Ryo, K, Haugaa, K, Saba, S, and Gorcsan, J
- Abstract
Background: Left atrial (LA) dysfunction and conduction alterations are observed in hypertrophic cardiomyopathy (HCM). P wave dispersion (PWD) reflects heterogenous atrial conduction. Another non-invasive method of assessing electrical events is the measurement of intra- and interatrial conduction times by tissue Doppler imaging (TDI). The aim of this study was to evaluate PWD, the intra- and interatrial asynchrony and their relations with LA volume index (LAVI), LA ejection fraction (LAEF) and plasma NT-proBNP levels in patients with HCM. Methods: Seventy patients with HCM and age and sex matched 70 subjects were enrolled. PWD was calculated on a high resolution computer screen after the magnification of ECG recordings. LA volume at end-ventricular systole (LAVmax) and end-atrial emptying (LAVmin) was assessed by TTE. LAEF was calculated as [(LAVmax-LAVmin)/LAVmax x 100]. Intra- and interatrial electromechanical conduction times were calculated by TDI. The time intervals from initiation of the P wave on ECG to the peak of the late diastolic TDI signal (A□) at the lateral border of the mitral (mitral PA□), septal (septal PA□) and the tricuspid annulus (tricuspid PA□) were measured. Interatrial asynchrony was defined as the difference between the mitral PA□ and tricuspid PA□ intervals, while intraatrial asynchrony as the difference between septal PA□ and tricuspid PA□ intervals. Plasma NT-proBNP levels were determined. Results: PWD was significantly higher in HCM group than in controls (43.5 ± 16.29 vs 37.07 ±10.61 ms, p=0.006). PWD correlated with LAVI (r=0.348, p=0.003) and LAEF (r=-0.242, p=0.044) but not related with log NT-proBNP levels (p=0.927). In HCM group interatrial electromechanical delay (42.29 ± 17.87 vs 27.64 ± 12.27 ms, p<0.001) and intraatrial electromechanical delay (25.43 ± 17.33 vs 13.57 ± 8.43 ms, p<0.001) were longer . Both intra- and interatrial asynchrony were not associated with LAVI, but significantly correlated with LAEF (r=-0.336, p=0.004 and r=-0.256, p=0.03, respectively). Intraatrial asynchrony was directly correlated with log NT-proBNP (r=0.309, p=0.012) in HCM group, while no association was detected between interatrial asynchrony and log NT-proBNP levels (p=0.102). Conclusion: Prolonged PWD, intra- and interatrial asynchrony were observed in patients with HCM and these parameters inversely correlated with LAEF. Intraatrial asynchrony was related to NT–proBNP levels. These observations seem to be related with fragmentation and slowing of atrial conduction activity which might be a result of atrial myopathy detected in HCM.
- Published
- 2013
- Full Text
- View/download PDF
33. Club 35 Poster Session Wednesday 11 December: 11/12/2013, 09:30-16:00 * Location: Poster area
- Author
-
Montoro Lopez, M, Pons De Antonio, I, Itziar Soto, C, Florez Gomez, R, Alonso Ladreda, A, Rios Blanco, JJ, Refoyo Salicio, E, Moreno Yanguela, M, Lopez Sendon, JL, Guzman Martinez, G, Van De Heyning, C M, Magne, J, Pierard, LA, Bruyere, PJ, Davin, L, De Maeyer, C, Paelinck, BP, Vrints, CJ, Lancellotti, P, Michalski, BW, Krzeminska-Pakula, M, Lipiec, P, Szymczyk, E, Chrzanowski, L, Kasprzak, JD, Leao, R N, Florencio, A F, Oliveira, A R, Bento, B, Lopes, S, Calaca, J, Palma Reis, R, Krestjyaninov, MV, Gimaev, RH, Razin, VA, Arangalage, D, Chiampan, A, Cimadevilla, C, Touati, A, Himbert, D, Brochet, E, Iung, B, Nataf, P, Vahanian, A, Messika-Zeitoun, D, Guvenc, TS, Karacimen, D, Erer, HB, Ilhan, E, Sayar, N, Karakus, G, Eren, M, Iriart, X, Tafer, N, Roubertie, F, Mauriat, P, Thambo, JB, Wang, J, Fang, F, Yip, G WK, Sanderson, J, Feng, W, Yu, CM, Lam, YY, Assabiny, A, Apor, A, Nagy, A, Vago, H, Toth, A, Merkely, B, Kovacs, A, Castaldi, B, Vida, VL, Guariento, A, Padalino, M, Cerutti, A, Maschietto, N, Biffanti, R, Reffo, E, Stellin, G, Milanesi, O, Baronaite-Dudoniene, K, Urbaite, L, Smalinskas, V, Veisaite, R, Vasylius, T, Vaskelyte, J, Puodziukynas, A, Wieczorek, J, Rybicka-Musialik, A, Berger-Kucza, A, Hoffmann, A, Wnuk-Wojnar, A, Mizia-Stec, K, Melao, F, Ribeiro, V, Amorim, S, Araujo, C, Torres, JP, Cardoso, JS, Pinho, P, Maciel, MJ, Storsten, P, Eriksen, M, Boe, E, Estensen, ME, Erikssen, G, Smiseth, OA, Skulstad, H, Miglioranza, MH, Gargani, L, Sant`Anna, RT, Rover, M, Martins, VM, Mantovanni, A, Kalil, RK, Leiria, TL, Luo, XX, Fang, F, Lee, PW, Zhang, ZH, Lam, YY, Sanderson, JE, Kwong, J SW, Yu, CM, Borowiec, A, Dabrowski, R, Wozniak, J, Jasek, S, Chwyczko, T, Kowalik, I, Janas, J, Musiej-Nowakowska, E, Szwed, H, Palinsky, M, Petrovicova, J, Pirscova, M, Baricevic, Z, Lovric, D, Cikes, M, Skoric, B, Ljubas Macek, J, Reskovic Luksic, V, Separovic Hanzevacki, J, Milicic, D, Elmissiri, AM, El Shahid, GS, Abdal-Wahhab, S, Vural, M G, Yilmaz, M, Cetin, S, Akdemir, R, Yoldas, T K, Yeter, E, Karamanou, AG, Hamodraka, ES, Lekakis, IA, Paraskevaidis, IA, Kremastinos, DT, Appiah-Dwomoh, E K, Wang, VC, Otto, C, Mayar, F, Bonaventura, K, Sunman, H, Canpolat, U, Kuyumcu, M, Yorgun, H, Sahiner, L, and Ozer, N
- Abstract
Purpose: It is known the higher prevalence of structural heart disease in HIV patients, mostly diastolic dysfunction and pulmonary hypertension. In spite of that, there are few data about predisposing factors. Our objective was to evaluate whether HIV stage or detectable blood viral load correlate with the degree of heart disease. Methods: We conducted a prospective cohort study with HIV patients monitored by the internal medicine unit of our institution. We selected symptomatic patients with functional class ≥ II of NYHA scale. Viral blood load and CD4 count were systematically determined in order to obtain the HIV stage. Patients underwent a transthoracic echocardiogram to assess ventricular hypertrophy, systolic and diastolic dysfunction and pulmonary hypertension, according to the limits set by ESC guidelines. Results: Data were obtained from 65 HIV patients with dyspnea (63% male) with a mean age of 48 years. 50% were in NYHA grade II, 32.3% III and 17.7% IV. 46.7% of patients had some data of structural heart disease (figure). Belong to AIDS group (65.3%) did not correlate with the degree of heart disease. However, patients with positive blood viral load had a significantly higher incidence of structural heart disease than those with undetectable load (75% vs. 43% p <0.04), independent of their cardiovascular risk profile or type of antiretroviral therapy (Table). Conclusion: In our experience, half of HIV patients with dyspnea show echocardiographic data of structural heart disease. Detectable viral load in blood doubles the prevalence of heart disease, so that HIV itself may be an independent causal agent. These data should be taken into account in the screening of structural heart disease in these patients.
Figure Prevalence of structural heart disease - Published
- 2013
- Full Text
- View/download PDF
34. Quality control of B-lines analysis in stress Echo 2020
- Author
-
Scali, M. C., Ciampi, Q., Picano, E., Bossone, E., Ferrara, F., Citro, R., Colonna, P., Costantino, M. F., Cortigiani, L., Andrea, A. D., Severino, S., Dodi, C., Gaibazzi, N., Galderisi, M., Barbieri, A., Monte, I., Mori, F., Reisenhofer, B., Re, F., Rigo, F., Trambaiolo, P., Amor, M., Lowenstein, J., Merlo, P. M., Daros, C. B., De Castro E Silva Pretto, J. L., Miglioranza, M. H., Torres, M. A. R., De Azevedo Bellagamba, C. C., Chaves, D. Q., Simova, I., Varga, A., Celutkiene, J., Kasprzak, J. D., Wierzbowska-Drabik, K., Lipiec, P., Weiner-Mik, P., Szymczyk, E., Wdowiak-Okrojek, K., Djordjevic-Dikic, A., Dekleva, M., Stankovic, I., Neskovic, A. N., Zagatina, A., Di Salvo, G., Perez, J. E., Camarozano, A. C., Corciu, A. I., Boshchenko, A., Lattanzi, F., Cotrim, C., Fazendas, P., Haberka, M., Sobkowic, B., Kosmala, W., Witkowski, T., Gosciniak, P., Salustri, A., Rodriguez-Zanella, H., Leal, L. I. M., Nikolic, A., Gligorova, S., Urluescu, M. -L., Fiorino, M., Novo, G., Preradovic-Kovacevic, T., Ostojic, M., Beleslin, B., Villari, B., De Nes, M., Paterni, M., Carpeggiani, C., Andreassi, M. G., Scali, Maria Chiara, Ciampi, Quirino, Picano, Eugenio, Bossone, Eduardo, Ferrara, Francesco, Citro, Rodolfo, Colonna, Paolo, Costantino, Marco Fabio, Cortigiani, Lauro, Andrea, Antonello D'., Severino, Sergio, Dodi, Claudio, Gaibazzi, Nicola, Galderisi, Maurizio, Barbieri, Andrea, Monte, Ine, Mori, Fabio, Reisenhofer, Barbara, Re, Federica, Rigo, Fausto, Trambaiolo, Paolo, Amor, Miguel, Lowenstein, Jorge, Merlo, Pablo Martin, Daros, Clarissa Borguezan, De Castro E Silva Pretto, José Lui, Miglioranza, Marcelo Haertel, Torres, Marco A. R., De Azevedo Bellagamba, Clarissa Carmona, Chaves, Daniel Quesada, Simova, Iana, Varga, Albert, Čelutkiene, Jelena, Kasprzak, Jaroslaw D., Wierzbowska-Drabik, Karina, Lipiec, Piotr, Weiner-Mik, Paulina, Szymczyk, Eva, Wdowiak-Okrojek, Katarzyna, Djordjevic-Dikic, Ana, Dekleva, Milica, Stankovic, Ivan, Neskovic, Aleksandar N., Zagatina, Angela, Di Salvo, Giovanni, Perez, Julio E., Camarozano, Ana Cristina, Corciu, Anca Irina, Boshchenko, Alla, Lattanzi, Fabio, Cotrim, Carlo, Fazendas, Paula, Haberka, Maciej, Sobkowic, Bozena, Kosmala, Wojciech, Witkowski, Tomasz, Gosciniak, Piotr, Salustri, Alessandro, Rodriguez-Zanella, Hugo, Leal, Luis Ignacio Martin, Nikolic, Alexandra, Gligorova, Suzana, Urluescu, Madalina-Loredana, Fiorino, Maria, Novo, Giuseppina, Preradovic-Kovacevic, Tamara, Ostojic, Miodrag, Beleslin, Branko, Villari, Bruno, De Nes, Michele, Paterni, Marco, Carpeggiani, Clara, Andreassi, Maria Grazia, Scali, Mc, Ciampi, Q, Picano, E, Bossone, E, Ferrara, F, Citro, R, Colonna, P, Costantino, Mf, Cortigiani, L, D'Andrea, A, Severino, S, Dodi, C, Gaibazzi, N, Galderisi, M, Barbieri, A, Monte, I, Mori, F, Reisenhofer, B, Re, F, Rigo, F, Trambaiolo, P, Amor, M, Lowenstein, J, Merlo, Pm, Daros, Cb, Pretto, Jlde, Miglioranza, Mh, Torres, Mar, Bellagamba, Ccd, Chaves, Dq, Simova, I, Varga, A, Celutkiene, J, Kasprzak, Jd, Wierzbowska-Drabik, K, Lipiec, P, Weiner-Mik, P, Szymczyk, E, Wdowiak-Okrojek, K, Djordjevic-Dikic, A, Dekleva, M, Stankovic, I, Neskovic, An, Zagatina, A, Di Salvo, G, Perez, Je, Camarozano, Ac, Corciu, Ai, Boshchenko, A, Lattanzi, F, Cotrim, C, Fazendas, P, Haberka, M, Sobkowic, B, Kosmala, W, Witkowski, T, Gosciniak, P, Salustri, A, Rodriguez-Zanella, H, Leal, Lim, Nikolic, A, Gligorova, S, Urluescu, Ml, Fiorino, M, Novo, G, Preradovic-Kovacevic, T, Ostojic, M, Beleslin, B, Villari, B, De Nes, M, Paterni, M, and Carpeggiani, C
- Subjects
Male ,lcsh:Diseases of the circulatory (Cardiovascular) system ,Diagnostic accuracy ,030204 cardiovascular system & hematology ,0302 clinical medicine ,Nuclear Medicine and Imaging ,Reading (process) ,Medicine ,Lung ,media_common ,Controle de qualidade ,certification ,lung comets ,quality control ,stress echocardiography ,wall motion ,General Medicine ,Middle Aged ,Echocardiography ,Female ,Radiology ,Cardiology and Cardiovascular Medicine ,Human ,Echocardiography, Stress ,Quality Control ,Certification ,Lung comets ,Quality control ,Stress echocardiography ,Wall motion ,Humans ,Internet ,Pulmonary Edema ,Radiology, Nuclear Medicine and Imaging ,medicine.medical_specialty ,Correlation coefficient ,media_common.quotation_subject ,Stress ,Lung comet ,Ecocardiografia sob estresse ,03 medical and health sciences ,Echocardiography, Stre ,Internal medicine ,Radiology, Nuclear Medicine and imaging ,Quality (business) ,Doenças cardiovasculares ,business.industry ,030208 emergency & critical care medicine ,Gold standard (test) ,Lung ultrasound ,lcsh:RC666-701 ,Stress Echo ,Nuclear medicine ,business ,Certificação - Abstract
Background The effectiveness trial “Stress echo (SE) 2020” evaluates novel applications of SE in and beyond coronary artery disease. The core protocol also includes 4-site simplified scan of B-lines by lung ultrasound, useful to assess pulmonary congestion. Purpose To provide web-based upstream quality control and harmonization of B-lines reading criteria. Methods 60 readers (all previously accredited for regional wall motion, 53 B-lines naive) from 52 centers of 16 countries of SE 2020 network read a set of 20 lung ultrasound video-clips selected by the Pisa lab serving as reference standard, after taking an obligatory web-based learning 2-h module ( http://se2020.altervista.org ). Each test clip was scored for B-lines from 0 (black lung, A-lines, no B-lines) to 10 (white lung, coalescing B-lines). The diagnostic gold standard was the concordant assessment of two experienced readers of the Pisa lab. The answer of the reader was considered correct if concordant with reference standard reading ±1 (for instance, reference standard reading of 5 B-lines; correct answer 4, 5, or 6). The a priori determined pass threshold was 18/20 (≥ 90%) with R value (intra-class correlation coefficient) between reference standard and recruiting center) > 0.90. Inter-observer agreement was assessed with intra-class correlation coefficient statistics. Results All 60 readers were successfully accredited: 26 (43%) on first, 24 (40%) on second, and 10 (17%) on third attempt. The average diagnostic accuracy of the 60 accredited readers was 95%, with R value of 0.95 compared to reference standard reading. The 53 B-lines naive scored similarly to the 7 B-lines expert on first attempt (90 versus 95%, p = NS). Compared to the step-1 of quality control for regional wall motion abnormalities, the mean reading time per attempt was shorter (17 ± 3 vs 29 ± 12 min, p
- Published
- 2018
35. Performance of the SHARPEN Score and the Charlson Comorbidity Index for In-Hospital and Post-Discharge Mortality Prediction in Infective Endocarditis.
- Author
-
Alves SG, Pivatto Júnior F, Filippini FB, Dannenhauer GP, Seroiska G, Bischoff HM, Birk LFS, Terra DH, Sganzerla D, and Miglioranza MH
- Subjects
- Humans, Aftercare, Retrospective Studies, Hospitals, Comorbidity, Patient Discharge, Endocarditis
- Abstract
Background: Central Illustration : Performance of the SHARPEN Score and the Charlson Comorbidity Index for In-Hospital and Post-Discharge Mortality Prediction in Infective Endocarditis., Background: SHARPEN was the first dedicated score for in-hospital mortality prediction in infective endocarditis (IE) regardless of cardiac surgery., Objectives: To analyze the ability of the SHARPEN score to predict in-hospital and post-discharge mortality and compare it with that of the Charlson comorbidity index (CCI)., Methods: Retrospective cohort study including definite IE (Duke modified criteria) admissions from 2000 to 2016. The area under the ROC curve (AUC-ROC) was calculated to assess predictive ability. Kaplan-Meier curves and Cox regression was performed. P-value < 0.05 was considered statistically significant., Results: We studied 179 hospital admissions. In-hospital mortality was 22.3%; 68 (38.0%) had cardiac surgery. Median (interquartile range, IQR) SHARPEN and CCI scores were 9(7-11) and 3(2-6), respectively. SHARPEN had better in-hospital mortality prediction than CCI in non-operated patients (AUC-ROC 0.77 vs. 0.62, p = 0.003); there was no difference in overall (p = 0.26) and in operated patients (p = 0.41). SHARPEN > 10 at admission was associated with decreased in-hospital survival in the overall (HR 3.87; p < 0.001), in non-operated (HR 3.46; p = 0.006) and operated (HR 6.86; p < 0.001) patients. CCI > 3 at admission was associated with worse in-hospital survival in the overall (HR 3.0; p = 0.002), and in operated patients (HR 5.57; p = 0.005), but not in non-operated patients (HR 2.13; p = 0.119). Post-discharge survival was worse in patients with SHARPEN > 10 (HR 3.11; p < 0.001) and CCI > 3 (HR 2.63; p < 0.001) at admission; however, there was no difference in predictive ability between these groups., Conclusion: SHARPEN was superior to CCI in predicting in-hospital mortality in non-operated patients. There was no difference between the scores regarding post-discharge mortality.
- Published
- 2024
- Full Text
- View/download PDF
36. Position Statement on the Use of Myocardial Strain in Cardiology Routines by the Brazilian Society of Cardiology's Department Of Cardiovascular Imaging - 2023.
- Author
-
Almeida ALC, Melo MDT, Bihan DCSL, Vieira MLC, Pena JLB, Del Castillo JM, Abensur H, Hortegal RA, Otto MEB, Piveta RB, Dantas MR, Assef JE, Beck ALS, Santo THCE, Silva TO, Salemi VMC, Rocon C, Lima MSM, Barberato SH, Rodrigues AC, Rabschkowisky A, Frota DDCR, Gripp EA, Barretto RBM, Silva SME, Cauduro SA, Pinheiro AC, Araujo SP, Tressino CG, Silva CES, Monaco CG, Paiva MG, Fisher CH, Alves MSL, Grau CRPC, Santos MVCD, Guimarães ICB, Morhy SS, Leal GN, Soares AM, Cruz CBBV, Guimarães Filho FV, Assunção BMBL, Fernandes RM, Saraiva RM, Tsutsui JM, Soares FLJ, Falcão SNDRS, Hotta VT, Armstrong ADC, Hygidio DA, Miglioranza MH, Camarozano AC, Lopes MMU, Cerci RJ, Siqueira MEM, Torreão JA, Rochitte CE, and Felix A
- Subjects
- Humans, Echocardiography, Doppler, Brazil, Heart Atria diagnostic imaging, Ventricular Function, Left, Atrial Fibrillation diagnostic imaging, Cardiology, Ventricular Dysfunction, Left
- Abstract
Central Illustration : Position Statement on the Use of Myocardial Strain in Cardiology Routines by the Brazilian Society of Cardiology's Department Of Cardiovascular Imaging - 2023 Proposal for including strain in the integrated diastolic function assessment algorithm, adapted from Nagueh et al.67 Am: mitral A-wave duration; Ap: reverse pulmonary A-wave duration; DD: diastolic dysfunction; LA: left atrium; LASr: LA strain reserve; LVGLS: left ventricular global longitudinal strain; TI: tricuspid insufficiency. Confirm concentric remodeling with LVGLS. In LVEF, mitral E wave deceleration time < 160 ms and pulmonary S-wave < D-wave are also parameters of increased filling pressure. This algorithm does not apply to patients with atrial fibrillation (AF), mitral annulus calcification, > mild mitral valve disease, left bundle branch block, paced rhythm, prosthetic valves, or severe primary pulmonary hypertension.
- Published
- 2023
- Full Text
- View/download PDF
37. Lung ultrasound in acute and chronic heart failure: a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI).
- Author
-
Gargani L, Girerd N, Platz E, Pellicori P, Stankovic I, Palazzuoli A, Pivetta E, Miglioranza MH, Soliman-Aboumarie H, Agricola E, Volpicelli G, Price S, Donal E, Cosyns B, and Neskovic AN
- Subjects
- Humans, Ultrasonography methods, Lung diagnostic imaging, Heart Failure diagnostic imaging
- Abstract
Competing Interests: Conflict of interest: Dr. Gargani: no conflict of interest related to this paper. Outside of this paper, Dr. Gargani has received consultancy honoraria from Philips Helathcare, GE Healthcare, Caption Health, EchoNous. Dr. Girerd: no conflict of interest related to this paper. Outside of this paper, Dr. Girerd has received consultancy honoraria from Astra Zeneca, Bayer, Boehringer-Ingelheim, Novartis, Lilly, Vifor International. Dr. Platz: no conflict of interest related to this paper. Outside of this paper, Dr. Platz’ employer has received support from Novartis for consulting work, and she has consulted for scPharmaceuticals. She has received research support from the NIH (R01HL148439), the American Heart Association and AstraZeneca. Dr. Pellicori: no conflict of interest related to this paper. Outside of this paper, Dr. Pellicori has received consultancy honoraria and/or sponsorship support from Boehringer Ingelheim, Pharmacosmos, Novartis, Vifor, AstraZeneca and Caption Health, and researchsupport from Bristol Myers Squibb. Dr. Stankovic: no conflict of interest related to this paper. Outside of this paper, Dr. Stankovic has received consultancy honoraria from Servier, Boehringer-Ingelheim, Pfizer, Astra Zeneca, Novartis, Merck Sharp & Dohme. Dr. Palazzuoli: no conflict of interest to declare. Dr. Pivetta: no conflict of interest related to this paper. Outside of this paper, Dr. Pivetta has received research support from Butterfly inc. Dr. Miglioranza: no conflict of interest related to this paper. Outside of this paper, Dr. Miglioranza has received consultancy honoraria from Philips, GE Healthcare, Abbott. Dr. Aboumarie: no conflict of interest to declare. Dr. Agricola: no conflict of interest related to this paper. Outside of this paper, Dr. Agricola has received consultancy honoraria from Philips, Edwards Lifesciences. Dr. Volpicelli: no conflict of interest to declare. Dr. Price: no conflict of interest to declare. Dr. Donal: no conflict of interest related to this paper. Outside of this paper, Dr. Donal has received research funding from Abbott. Dr. Cosyns: no conflict of interest related to this paper. Outside of this paper, Dr. Cosyns has received research funding from Abbott. Dr. Neskovic: no conflict of interest related to this paper. Outside of this paper, Dr. Neskovic has received consultancy honoraria from Bayer, AstraZeneca, Pfizer, Boehringer Ingelheim, Servier and Novartis.
- Published
- 2023
- Full Text
- View/download PDF
38. Use of cardiac imaging in chronic coronary syndromes: the EURECA Imaging registry.
- Author
-
Neglia D, Liga R, Gimelli A, Podlesnikar T, Cvijić M, Pontone G, Miglioranza MH, Guaricci AI, Seitun S, Clemente A, Sumin A, Vitola J, Saraste A, Paunonen C, Sia CH, Paleev F, Sade LE, Zamorano JL, Maroz-Vadalazhskaya N, Anagnostopoulos C, Macedo F, Knuuti J, Edvardsen T, Cosyns B, Petersen SE, Magne J, Laroche C, Berlè C, Popescu BA, and Delgado V
- Subjects
- Male, Humans, Middle Aged, Aged, Female, Coronary Angiography methods, Prospective Studies, Tomography, X-Ray Computed methods, Computed Tomography Angiography, Predictive Value of Tests, Quality of Life, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease therapy
- Abstract
Background: The prospective, multicentre EURECA registry assessed the use of imaging and adoption of the European Society of Cardiology (ESC) Guidelines (GL) in patients with chronic coronary syndromes (CCS)., Methods: Between May 2019 and March 2020, 5156 patients were recruited in 73 centres from 24 ESC member countries. The adoption of GL recommendations was evaluated according to clinical presentation and pre-test probability (PTP) of obstructive coronary artery disease (CAD)., Results: The mean age of the population was 64 ± 11 years, 60% of patients were males, 42% had PTP >15%, 27% had previous CAD, and ejection fraction was <50% in 5%. Exercise ECG was performed in 32% of patients, stress imaging as the first choice in 40%, and computed tomography coronary angiography (CTCA) in 22%. Invasive coronary angiography (ICA) was the first or downstream test in 17% and 11%, respectively. Obstructive CAD was documented in 24% of patients, inducible ischaemia in 19%, and 13% of patients underwent revascularization. In 44% of patients, the overall diagnostic process did not adopt the GL. In these patients, referral to stress imaging (21% vs. 58%; P < 0.001) or CTCA (17% vs. 30%; P < 0.001) was less frequent, while exercise ECG (43% vs. 22%; P < 0.001) and ICA (48% vs. 15%; P < 0.001) were more frequently performed. The adoption of GL was associated with fewer ICA, higher proportion of diagnosis of obstructive CAD (60% vs. 39%, P < 0.001) and revascularization (54% vs. 37%, P < 0.001), higher quality of life, fewer additional testing, and longer times to late revascularization., Conclusions: In patients with CCS, current clinical practice does not adopt GL recommendations on the use of diagnostic tests in a significant proportion of patients. When the diagnostic approach adopts GL recommendations, invasive procedures are less frequently used and the diagnostic yield and therapeutic utility are superior., Competing Interests: Conflict of interest: C.-H.S., R.L., M.H.M., D.N., A.S., J.V., A.C., A.I.G., S.S., C.B., C.L., F.P., T.P., M.C., F.M., T.E., B.C., J.M., C.A., and B.A.P. declare no conflict of interest. A.G. reports consultancy to Pfizer and GE Healthcare (paid to FTGM). J.L.Z. reports a grant from Abbott and honoraria from Bayer, Daichii, Pfizer, and Edwards. G.P. reports grants, honoraria or consulting fees, honorarium as speaker, and/or institutional research funding from GE Healthcare, Bracco, Boehringer, Heartflow. J.K. reports honoraria from GE Healthcare, Merck, Lundbeck, Bayer, Boehringer-Ingelheim, Pfizer. S.E.P. reports consultancy to and stock ownership of Circle Cardiovascular Imaging Inc, Calgary, Alberta, Canada. V.D. reports grants or contracts from Abbott Vascular, Bayer, Bioventrix, Boston Scientific, Edwards Lifesciences, GE Healthcare, Ionis, Medtronic (paid to the Department of Cardiology of the Leiden University Medical Center). Honoraria from Abbott Vascular, Edwards Lifesciences, GE Healthcare, MSD, Novartis, Medtronic. N.M.-V. reports a leadership or fiduciary role: Member of expert board of Belarusian Republican Foundation for Fundamental Research. A.S. reports honoraria from Abbott, Amgen, Astra Zeneca, Bayer, Boehringer-Ingelheim, and Pfizer., (© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
39. Left atrial strain determinants and clinical features according to the heart failure stages. New insight from EACVI MASCOT registry.
- Author
-
Benfari G, Mandoli GE, Magne J, Miglioranza MH, Ancona R, Luksic VR, Pastore MC, Santoro C, Michalski B, Malagoli A, Muraru D, Donal E, Cosyns B, Edvardsen T, Popescu BA, and Cameli M
- Subjects
- Humans, Prospective Studies, Predictive Value of Tests, Registries, Heart Atria diagnostic imaging, Heart Failure diagnostic imaging
- Abstract
Few studies analyzed left atrial (LA) peak atrial longitudinal strain (PALS) determinants, particularly across heart failure (HF) stages. We aimed to analyze the pathophysiological and clinical PALS correlates in a large multicentric prospective study. This is a multicenter prospective observational study enrolling 745 patients with HF stages. Data included PALS and left ventricular global longitudinal strain (LV-GLS). Exclusion criteria were: valvular prosthesis; atrial fibrillation; cardiac transplantation; poor acoustic window. Median global PALS was 17% [24-32]. 29% of patients were in HF-stage 0/A, 35% in stage-B, and 36% in stage-C. Together with age, the echocardiographic determinants of PALS were LA volume and LV-GLS (overall model R
2 = 0.50, p < 0.0001). LV-GLS had the strongest association with PALS at multivariable analysis (beta: -3.60 ± 0.20, p < 0.0001). Among HF stages, LV-GLS remained the most important PALS predictor (p < 0.0001) whereas age was only associated with PALS in lower HF-stage 0/A or B (R = - 0.26 p < 0.0001, R = - 0.23 p = 0.0001). LA volume increased its association to PALS moving from stage 0/A (R = - 0.11; P = 0.1) to C (R = - 0.42; P < 0.0001). PALS was the single most potent echocardiographic parameter in predicting the HF stage (AUC for B vs. 0/A 0.81, and AUC vs. 0/A for C 0.76). PALS remained independently associated with HF stages after adjusting for ejection fraction, E/e' ratio, and mitral regurgitation grade (p < 0.0001). Although influenced by LV-GLS and LA size across HF stages, PALS is incrementally and independently associated with clinical status. LA function may reflect a substantial part of the hemodynamic consequences of ventricular dysfunction., (© 2022. The Author(s).)- Published
- 2022
- Full Text
- View/download PDF
40. Clinical profile and outcome of recurrent infective endocarditis.
- Author
-
Citro R, Chan KL, Miglioranza MH, Laroche C, Benvenga RM, Furnaz S, Magne J, Olmos C, Paelinck BP, Pasquet A, Piper C, Salsano A, Savouré A, Park SW, Szymański P, Tattevin P, Vallejo Camazon N, Lancellotti P, and Habib G
- Subjects
- Female, Hospital Mortality, Humans, Male, Middle Aged, Recurrence, Reinfection, Retrospective Studies, Endocarditis diagnosis, Endocarditis surgery, Endocarditis, Bacterial diagnosis, Endocarditis, Bacterial surgery, Staphylococcal Infections diagnosis, Staphylococcal Infections surgery
- Abstract
Aims: Purpose of this study is to compare the clinical course and outcome of patients with recurrent versus first-episode infective endocarditis (IE)., Methods: Patients with recurrent and first-episode IE enrolled in the EUROpean ENDOcarditis (EURO-ENDO) registry including 156 centres were identified and compared using propensity score matching. Recurrent IE was classified as relapse when IE occurred ≤6 months after a previous episode or reinfection when IE occurred >6 months after the prior episode., Results: 3106 patients were enrolled: 2839 (91.4%) patients with first-episode IE (mean age 59.4 (±18.1); 68.3% male) and 267 (8.6%) patients with recurrent IE (mean age 58.1 (±17.7); 74.9% male). Among patients with recurrent IE, 13.2% were intravenous drug users (IVDUs), 66.4% had a repaired or replaced valve with the tricuspid valve being more frequently involved compared with patients with first-episode IE (20.3% vs 14.1%; p=0.012). In patients with a first episode of IE, the aortic valve was more frequently involved (45.6% vs 39.5%; p=0.061). Recurrent relapse and reinfection were 20.6% and 79.4%, respectively. Staphylococcus aureus was the microorganism most frequently observed in both groups (p=0.207). There were no differences in in-hospital and post-hospitalisation mortality between recurrent and first-episode IE. In patients with recurrent IE, in-hospital mortality was higher in IVDU patients. Independent predictors of poorer in-hospital and 1-year outcome, including the occurrence of cardiogenic and septic shock, valvular disease severity and failure to undertake surgery when indicated, were similar for recurrent and first-episode IE., Conclusions: In-hospital and 1-year mortality was similar in patients with recurrent and first-episode IE who shared similar predictors of poor outcome., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
41. Correction to: Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry.
- Author
-
Pazdernik M, Iung B, Mutlu B, Alla F, Riezebos R, Kong W, Nunes MCP, Pierard L, Srdanovic I, Yamada H, De Martino A, Miglioranza MH, Magne J, Piper C, Laroche C, Maggioni AP, Lancellotti P, Habib G, and Selton-Suty C
- Published
- 2022
- Full Text
- View/download PDF
42. Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry.
- Author
-
Pazdernik M, Iung B, Mutlu B, Alla F, Riezebos R, Kong W, Nunes MCP, Pierard L, Srdanovic I, Yamada H, De Martino A, Miglioranza MH, Magne J, Piper C, Laroche C, Maggioni AP, Lancellotti P, Habib G, and Selton-Suty C
- Subjects
- Aged, 80 and over, Hospital Mortality, Humans, Octogenarians, Prospective Studies, Registries, Endocarditis epidemiology, Endocarditis surgery, Endocarditis, Bacterial epidemiology
- Abstract
Purpose: High mortality and a limited performance of valvular surgery are typical features of infective endocarditis (IE) in octogenarians, even though surgical treatment is a major determinant of a successful outcome in IE., Methods: Data from the prospective multicentre ESC EORP EURO-ENDO registry were used to assess the prognostic role of valvular surgery depending on age., Results: As compared to < 80 yo patients, ≥ 80 yo had lower rates of theoretical indication for valvular surgery (49.1% vs. 60.3%, p < 0.001), of surgery performed (37.0% vs. 75.5%, p < 0.001), and a higher in-hospital (25.9% vs. 15.8%, p < 0.001) and 1-year mortality (41.3% vs. 22.2%, p < 0.001). By multivariable analysis, age per se was not predictive of 1-year mortality, but lack of surgical procedures when indicated was strongly predictive (HR 2.98 [2.43-3.66]). By propensity analysis, 304 ≥ 80 yo were matched to 608 < 80 yo patients. Propensity analysis confirmed the lower rate of indication for valvular surgery (51.3% vs. 57.2%, p = 0.031) and of surgery performed (35.3% vs. 68.4%, p < 0.0001) in ≥ 80 yo. Overall mortality remained higher in ≥ 80 yo (in-hospital: HR 1.50[1.06-2.13], p = 0.0210; 1-yr: HR 1.58[1.21-2.05], p = 0.0006), but was not different from that of < 80 yo among those who had surgery (in-hospital: 19.7% vs. 20.0%, p = 0.4236; 1-year: 27.3% vs. 25.5%, p = 0.7176)., Conclusion: Although mortality rates are consistently higher in ≥ 80 yo patients than in < 80 yo patients in the general population, mortality of surgery in ≥ 80 yo is similar to < 80 yo after matching patients. These results confirm the importance of a better recognition of surgical indication and of an increased performance of surgery in ≥ 80 yo patients., (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.)
- Published
- 2022
- Full Text
- View/download PDF
43. Speckle tracking echocardiography in primary mitral regurgitation: should we reconsider the time for intervention?
- Author
-
Pastore MC, Mandoli GE, Dokollari A, Bisleri G, D'Ascenzi F, Santoro C, Miglioranza MH, Focardi M, Cavigli L, Patti G, Valente S, Mondillo S, and Cameli M
- Subjects
- Echocardiography methods, Heart Ventricles, Humans, Quality of Life, Mitral Valve Insufficiency diagnostic imaging, Mitral Valve Insufficiency surgery, Ventricular Dysfunction, Right
- Abstract
Thanks to the improvement in mitral regurgitation (MR) diagnostic and therapeutic management, with the introduction of minimally invasive techniques which have considerably reduced the individual surgical risk, the optimization of the timing for MR "open" or percutaneous surgical treatment has become a main concern which has highly raised scientific interest. In fact, the current indications for intervention in MR, especially in asymptomatic patients, rely on echocardiographic criteria with high severity cut-offs that are fulfilled only when not only mitral valve apparatus but also the cardiac chambers' structure and function are severely impaired, which results in poor benefits for post-operative clinical outcome. This led to the need of new indices to redefine the optimal surgical timing in these patients. Speckle tracking echocardiography provides early markers of cardiac dysfunction due to subtle myocardial impairment; therefore, it could offer pivotal information in this setting. In fact, left ventricular and left atrial strains have already shown evidence about their usefulness in recognizing MR impact not only on symptoms and quality of life but also on cardiovascular events and new-onset atrial fibrillation in these patients. Moreover, right ventricular strain could be used to identify those patients with advanced cardiac damage and different grades of right ventricular dysfunction, which entails higher risks for cardiac surgery that could overweigh surgical benefits. This review aims to describe the importance of reconsidering the timing of intervention in MR and to analyze the potential additive value of speckle tracking echocardiography in this clinical setting., (© 2021. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
44. Preoperative TAVR Planning: How to Do It.
- Author
-
Saadi RP, Tagliari AP, Saadi EK, Miglioranza MH, and Polanczyck CA
- Abstract
Transcatheter aortic valve replacement (TAVR) is a well-established treatment option for patients with severe symptomatic aortic stenosis (AS) whose procedural efficacy and safety have been continuously improving. Appropriate preprocedural planning, including aortic valve annulus measurements, transcatheter heart valve choice, and possible procedural complication anticipation is mandatory to a successful procedure. The gold standard for preoperative planning is still to perform a multi-detector computed angiotomography (MDCT), which provides all the information required. Nonetheless, 3D echocardiography and magnet resonance imaging (MRI) are great alternatives for some patients. In this article, we provide an updated comprehensive review, focusing on preoperative TAVR planning and the standard steps required to do it properly.
- Published
- 2022
- Full Text
- View/download PDF
45. Brazilian Position Statement on the Use Of Multimodality Imaging in Cardio-Oncology - 2021.
- Author
-
Melo MDT, Paiva MG, Santos MVC, Rochitte CE, Moreira VM, Saleh MH, Brandão SCS, Gallafrio CC, Goldwasser D, Gripp EA, Piveta RB, Silva TO, Santo THCE, Ferreira WP, Salemi VMC, Cauduro SA, Barberato SH, Lopes HMC, Pena JLB, Rached HRS, Miglioranza MH, Pinheiro AC, Vrandecic BALM, Cruz CBBV, Nomura CH, Cerbino FME, Costa IBSDS, Coelho Filho OR, Carneiro ACC, Burgos UMMC, Fernandes JL, Uellendahl M, Calado EB, Senra T, Assunção BL, Freire CMV, Martins CN, Sawamura KSS, Brito MM, Jardim MFS, Bernardes RJM, Diógenes TC, Vieira LO, Mesquita CT, Lopes RW, Segundo Neto EMV, Rigo L, Marin VLS, Santos MJ, Grossman GB, Quagliato PC, Alcantara ML, Teodoro JAR, Albricker ACL, Barros FS, Amaral SID, Porto CLL, Barros MVL, Santos SND, Cantisano AL, Petisco ACGP, Barbosa JEM, Veloso OCG, Spina S, Pignatelli R, Hajjar LA, Kalil Filho R, Lopes MACQ, Vieira MLC, and Almeida ALC
- Subjects
- Brazil, Diagnostic Imaging, Humans, Medical Oncology, Neoplasms diagnostic imaging
- Published
- 2021
- Full Text
- View/download PDF
46. SHARPEN score accurately predicts in-hospital mortality in infective endocarditis.
- Author
-
Alves SG, Pivatto Júnior F, Filippini FB, Dannenhauer GP, and Miglioranza MH
- Subjects
- Hospital Mortality, Humans, Retrospective Studies, Risk Factors, Endocarditis, Endocarditis, Bacterial
- Published
- 2021
- Full Text
- View/download PDF
47. Two and Three-Dimensional Echocardiography in Primary Mitral Regurgitation: Practical Hints to Optimize the Surgical Planning.
- Author
-
Pastore MC, Mandoli GE, Sannino A, Dokollari A, Bisleri G, D'Ascenzi F, Cavigli L, Pasquini A, Lisi M, Ghionzoli N, Santoro C, Miglioranza MH, Focardi M, Patti G, Valente S, Mondillo S, and Cameli M
- Abstract
Primary mitral regurgitation (MR) is the second most common valvular disease, characterized by a high burden in terms of quality of life, morbidity, and mortality. Surgical treatment is considered the best therapeutic strategy for patients with severe MR, especially if they are symptomatic. However, pre-operative echocardiographic evaluation is an essential step not only for surgical candidate selection but also to avoid post-operative complications. Therefore, a strong collaboration between cardiologists and cardiac surgeons is fundamental in this setting. A meticulous pre-operative echocardiographic exam, both with transthoracic or transesophageal echocardiography, followed by a precise report containing anatomical information and parameters should always be performed to optimize surgical planning. Moreover, intraoperative transesophageal evaluation is often required by cardiac surgeons as it may offer additive important information with different hemodynamic conditions. Three-dimensional echocardiography has recently gained higher consideration and availability for the evaluation of MR, providing more insights into mitral valve geometry and MR mechanism. This review paper aims to realize a practical overview on the main use of basic and advanced echocardiography in MR surgical planning and to provide a precise checklist with reference parameters to follow when performing pre-operative echocardiographic exam, in order to aid cardiologists to provide a complete echocardiographic evaluation for MR operation planning from clinical and surgical point-of-view., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Pastore, Mandoli, Sannino, Dokollari, Bisleri, D'Ascenzi, Cavigli, Pasquini, Lisi, Ghionzoli, Santoro, Miglioranza, Focardi, Patti, Valente, Mondillo and Cameli.)
- Published
- 2021
- Full Text
- View/download PDF
48. Primary Soft Tissue Sarcoma of the Heart: An Emerging Chapter in Cardio-Oncology.
- Author
-
Scicchitano P, Sergi MC, Cameli M, Miglioranza MH, Ciccone MM, Gentile M, Porta C, and Tucci M
- Abstract
Primary malignant cardiac tumors are rare, with a prevalence of about 0.01% among all cancer histotypes. At least 60% of them are primary soft tissue sarcomas of the heart (pSTS-h) that represent almost 1% of all STSs. The cardiac site of origin is the best way to classify pSTS-h as it is directly linked to the surgical approach for cancer removal. Indeed, histological differentiation should integrate the classification to provide insights into prognosis and survival expectancy of the patients. The prognosis of pSTS-h is severe and mostly influenced by the primary localization of the tumor, the difficulty in achieving complete surgical and pharmacological eradication, and the aggressive biological features of malignant cells. This review aims to provide a detailed literature overview of the most relevant issues on primary soft tissue sarcoma of the heart and highlight potential diagnostic and therapeutic future perspectives.
- Published
- 2021
- Full Text
- View/download PDF
49. Position Statement on Indications and the Safe Reintroduction of Cardiovascular Imaging Methods in the COVID-19 Scenario - 2021.
- Author
-
Beck ALS, Barberato SH, Almeida ALC, Grau CRPC, Lopes MMU, Lima RSL, Cerci RJ, Albricker ACL, Barros FS, Oliveira AJ, Lira Filho EB, Miglioranza MH, Vieira MLC, Pena JLB, Strabelli TMV, Bihan DCSL, Tsutsui JM, and Rochitte CE
- Subjects
- Humans, SARS-CoV-2, Societies, Medical, COVID-19, Cardiovascular System
- Published
- 2021
- Full Text
- View/download PDF
50. Survival of Patients with Acute Heart Failure and Mid-range Ejection Fraction in a Developing Country - A Cohort Study in South Brazil.
- Author
-
Petersen LC, Danzmann LC, Bartholomay E, Bodanese LC, Donay BG, Magedanz EH, Azevedo AV, Porciuncula GF, and Miglioranza MH
- Subjects
- Adult, Brazil, Cohort Studies, Developing Countries, Humans, Prognosis, Stroke Volume, Heart Failure
- Abstract
Background: Heart Failure with mid-range Ejection Fraction (HFmEF) was recently described by European and Brazilian guidelines on Heart Failure (HF). The ejection fraction (EF) is an important parameter to guide therapy and prognosis. Studies have shown conflicting results without representative data from developing countries., Objective: To analyze and compare survival rate in patients with HFmEF, HF patients with reduced EF (HFrEF), and HF patients with preserved EF (HFpEF), and to evaluate the clinical characteristics of these patients., Methods: A cohort study that included adult patients with acute HF admitted through the emergency department to a tertiary hospital, reference in cardiology, in south Brazil from 2009 to 2011. The sample was divided into three groups according to EF: reduced, mid-range and preserved. A Kaplan-Meier curve was analyzed according to the EF, and a logistic regression analysis was done. Statistical significance was established as p < 0.05., Results: A total of 380 patients were analyzed. Most patients had HFpEF (51%), followed by patients with HFrEF (32%) and HFmEF (17%). Patients with HFmEF showed intermediate characteristics related to age, blood pressure and ventricular diameters, and most patients were of ischemic etiology. Median follow-up time was 4.0 years. There was no statistical difference in overall survival or cardiovascular mortality (p=.0031) between the EF groups (reduced EF: 40.5% mortality; mid-range EF 39.7% and preserved EF 26%). Hospital mortality was 7.6%., Conclusion: There was no difference in overall survival rate between the EF groups. Patients with HFmEF showed higher mortality from cardiovascular diseases in comparison with HFpEF patients. (Arq Bras Cardiol. 2021; 116(1):14-23).
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.